Subscription Agreement - Private Placement of 10M-13.3M Shares at $3.00/Share

EX-10.3 8 ea028609201ex10-3.htm FORM OF SUBSCRIPTION AGREEMENT, BY AND BETWEEN THE COMPANY AND THE PARTIES THERETO Exhibit 10.3

SUBSCRIPTION AGREEMENT

---

This Subscription
Agreement (this “ Agreement ”) has been entered into by and between the purchaser set forth on the Omnibus Signature
Page hereof (the “ Purchaser ”) and JDEV Acquisition Corp. (to be renamed “Ionetix Corp.” upon consummation
of the Merger (as defined below)), a Delaware corporation (the “ Company ”), in connection with the private placement
offering (the “ Offering ”) by the Company.

R E C I T A L S

---

A. The Company is offering a minimum of
10,000,000 shares of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”), at a
purchase price of $3.00 per share (the “ Per Share Purchase Price ”), for an aggregate purchase price of
$30,000,000 (the “ Minimum Offering Amount ”), and a maximum of 13,333,333 shares of Common Stock at the Per
Share Purchase Price for an aggregate purchase price of $40,000,000 (the “ Maximum Offering Amount ”). The
Company may also sell an additional 5,000,000 shares of Common Stock at the Per Share Purchase Price for an aggregate Purchase Price
of $15,000,000 to cover over-subscriptions (the “ Over-Subscription Option ”), in the event the Offering is
oversubscribed.

B. The
Initial Closing (as defined below) of no less than the Minimum Offering Amount, including any Insider Investment (as defined below), is
contingent upon, and shall be consummated simultaneously with, the closing of a reverse triangular merger in accordance with the terms
of that certain Agreement and Plan of Merger, dated as of the Initial Closing Date (as defined below) (the “ Merger Agreement ”),
by and among the Company, Ionetix Corp Acquisition Inc., a Delaware corporation (“ Merger-Sub ”) and wholly owned
Subsidiary of the Company, and Ionetix Corp., a Delaware corporation (“ Ionetix ”), pursuant to which Merger-Sub
will merge with and into Ionetix, with Ionetix surviving the merger as a wholly owned Subsidiary of the Company (the “ Merger ”),
and pursuant to which all of the outstanding capital stock of Ionetix will be cancelled in exchange for shares of the Company’s
Common Stock, and all outstanding Ionetix options, warrants, SAFEs and convertible debt will be either cancelled or assumed by, or exchanged
for new securities to acquire Common Stock of, the Company, at the same ratio at which outstanding shares of capital stock of Ionetix
are exchanged, with appropriate adjustments to the per share exercise or conversion price thereof, and otherwise on their original terms
and conditions. The total number of shares of the Company’s Common Stock that will be issued to pre-Merger stockholders of Ionetixor
reserved for issuance upon exercise of warrants, options and any other convertible securities of Ionetix is expected to be 110,000,000
shares, which includes 5,000,000 shares of Common Stock for the future issuance, at the discretion of the Company’s board of directors
(the “ Board of Directors ”) of options and other incentive awards to officers, key employees, consultants and
directors of the Company and its Subsidiaries under the Company’s Equity Incentive Plan (the “ EIP ”). The
number of shares initially reserved for issuance under the EIP will be increased annually on the first day of each month of January beginning
in 2027, at the discretion of the Board of Directors, in an amount up to four percent (4%) of the shares of stock outstanding (on an as-converted
basis) on the last day of the immediately preceding month. Holders of Common Stock of the Company prior to the Merger will retain in the
aggregate 5,500,000 shares of Common Stock after the Merger. On or before the consummation of the Merger, the Company will change its
name to “Ionetix Corp.,” and Ionetix will change its name to a name to be determined.

C. Certain
current officers, directors, and stockholders of Ionetix and their respective friends and family (“ Insider Investors ”)
will purchase shares of Common Stock in the Offering (an “ Insider Investment ”). The amount purchased by the
Insider Investors shall count towards the achievement of the Minimum Offering Amount and Maximum Offering Amount. The Placement Agent
(as defined below), together with their respective officers, directors, shareholders, employees and other affiliates may (but are not
obligated to) also purchase shares of Common Stock in the Offering (a “ Placement Agent Investment ”), and to
the extent they do so, such purchases will also be counted towards the achievement of the Minimum Offering Amount and Maximum Offering
Amount.

D.
The Shares (as defined below) subscribed for pursuant to this Agreement have not been registered under the Securities Act of 1933,
as amended, and the rules and regulations promulgated thereunder (the “ Securities Act ”) or any state or
foreign securities Law. The Offering is being made on a reasonable best efforts basis to “accredited investors,” as
defined in Regulation D under the Securities Act, in reliance upon the exemption from securities registration afforded by Section
4(a)(2) of the Securities Act and Rule 506 of Regulation D. For purposes of this Agreement, “ Law ” or
“ Laws ” means any federal, state, local or foreign or provincial statute, law (including, for the avoidance
of doubt, any statutory, common, or civil law), ordinance, rule, regulation, order, injunction, decree or agency requirement having
the force of law or any undertaking to or agreement with any Governmental Authority (as defined below).

E. The
parties intend to treat the Merger, together with the Initial Closing and the Subsequent Closing, if relevant, as part of a transaction
that is described in Section 351(a) of the Internal Revenue Code of 1986, as amended (the “ Code ”), to the extent
property is exchanged for stock as described therein.

AGREEMENT

The Company and the Purchaser hereby agree as follows:

| | 1. | Subscription. |

| | (a) | Purchase and Sale of the Shares. |

(i) Subject
to the terms and conditions of this Agreement, the Purchaser agrees to purchase, and the Company agrees to sell and issue to the Purchaser,
that number of Shares set forth on the Purchaser’s Omnibus Signature Page attached hereto at the Per Share Purchase Price, for a
total aggregate purchase price for the Shares as set forth on such Omnibus Signature Page (the “ Purchase Price ”).
The minimum subscription amount for each purchaser in the Offering is $100,000 (or 33,333 Shares). The Company may accept subscriptions
for less than $100,000 from any Purchaser in the Offering in its sole discretion. For the purposes of this Agreement, “ Shares ”
means the shares of Common Stock issued and sold to the Purchaser hereunder in the Offering at the Initial Closing (as defined below)
and at any Subsequent Closing (as defined below).

(ii) In
connection with the Offering, the Company has entered or will enter into other subscription agreements in the same form and containing
the same terms and conditions as this Agreement for shares of Common Stock (“ Other Shares ”) (each, an “ Other
Subscription Agreement ”) with purchasers in the Offering other than the Purchaser (collectively, “ Other Purchasers ”).

| | (b) | Subscription Procedure; Closing. |

(i) Initial
Closing. Subject to the terms and conditions of this Agreement, the initial closing of the Offering shall take place upon the satisfaction
(or waiver as provided herein) of the conditions set forth in Section 5 and Section 6 of this Agreement (other than those conditions that
by their nature will be satisfied at the Closing, but subject to the satisfaction (or waiver as provided herein) of such conditions) or
at such other time and place as is mutually agreed to by the Company and the Placement Agent contingent upon and simultaneously with the
closing of the Merger (the “ Initial Closing ” and the date that the Initial Closing occurs, the “ Initial
Closing Date ”).

(ii) Subsequent
Closings. If the Maximum Offering Amount is not sold at the Initial Closing, at any time prior to June 1, 2026, or at such later
date as the Company and Placement Agent may mutually agree, without notice to or consent from the Purchaser or any Other Purchaser,
subject to the satisfaction (or waiver as provided herein) of the conditions set forth in Section 5 and Section 6 of this Agreement
(other than those conditions that by their nature will be satisfied at the Closing, but subject to the satisfaction (or waiver as
provided herein) of such conditions) (each a “ Subsequent Closing ” and collectively the
“ Subsequent Closings ” and the date that a Subsequent Closing occurs, a “ Subsequent Closing
Date ”), the Company may sell additional shares of Common Stock up to the Maximum Offering Amount, and if there are
over-subscriptions, additional shares of Common Stock may be sold at the Per Share Purchase Price in connection with the
Over-Subscription Option (collectively, the “ Subsequent Closing Shares ”) to such persons as may be
approved by the Company and who are reasonably acceptable to the Placement Agent, including the Purchaser. Any Subsequent Closing
Shares issued and sold to the Purchaser pursuant to this Section 1 (b) (ii) shall be deemed to be “ Shares ”
for all purposes under this Agreement.

The Initial Closing
and the Subsequent Closings, if any, shall be known collectively herein as the “ Closings ” or individually as
a “ Closing.” The Initial Closing Date and the Subsequent Closing Dates are each referred to herein as a “ Closing
Date ”. Closings may take place remotely via the exchange by electronic transmission of documents and signatures.

2

(iii) Subscription
Procedure. To complete a subscription for the Shares, the Purchaser must fully comply with the subscription procedure provided in
subparagraphs (A) through (D) of this paragraph (iii) on or before the applicable Closing Date:

(A) Subscription
Documents. At or before the applicable Closing, the Purchaser shall review, complete and execute the Omnibus Signature Page to this
Agreement and the Registration Rights Agreement substantially in the form of Exhibit A hereto (the “ Registration Rights
Agreement ” ), the Selling Securityholder Questionnaire (as defined in the Registration Rights Agreement), the Purchaser
Profile, the Anti-Money Laundering Form and the Accredited Investor Certification, attached hereto following the Omnibus Signature Page
(collectively, the “ Subscription Documents ”), and deliver the Subscription Documents to the party indicated
thereon at the address set forth under the caption “ How to subscribe for Shares in the private offering of JDEV Acquisition
Corp. (to be renamed “Ionetix Corp. ” below. Executed documents may be delivered to such party by facsimile
or .pdf sent by electronic mail (e-mail).

(B) Purchase
Price. At or before the applicable Closing, the Purchaser shall deliver to CSC Delaware Trust Company, in its capacity as escrow agent
(the “ Escrow Agent ”), under an escrow agreement among the Company, Ionetix, the Placement Agent and the Escrow
Agent (the “ Escrow Agreement ”) the full Purchase Price set forth on the Purchaser’s Omnibus Signature
Page attached hereto, by certified or other bank check or by wire transfer of immediately available funds, pursuant to the instructions
set forth under the caption “ How to subscribe for Shares in the private offering of JDEV Acquisition Corp. (to be renamed *“Ionetix Corp.*** ” below. Such funds will be held for the Purchaser’s benefit in the escrow account established
for the Offering (the “ Escrow Account ”), without interest or offset.

(C) Termination.
This Agreement shall terminate automatically and be of no further force and effect, and any amounts deposited into the Escrow Account
by or on behalf of the Purchaser shall be returned to the Purchaser or its designee promptly, without interest or offset, if (i) the Purchaser
and the Company agree in writing to terminate this Agreement prior to the applicable Closing, (ii) the subscription has been revoked in
full by the Purchaser in accordance with Section 8, (iii) prior to the applicable Closing, in the Purchaser’s sole and absolute
discretion, upon written notice to the Company, if any representation or warranty of the Company set forth in Section 3 hereof
shall be or shall have become inaccurate or the Company shall have breached or failed to perform any of its covenants or other agreements
set forth in this Agreement, which inaccuracy, breach or failure to perform would give rise to the failure to satisfy any of the conditions
set forth in Section 6(a) or Section 6(b) of this Agreement and which inaccuracy, breach or failure to perform cannot be
cured by the Company or, if capable of being cured, is not cured within two (2) Business Days of the Purchaser’s notice to the Company
thereof; or (iv) the Merger Agreement is terminated pursuant to its terms. For the purposes of this Agreement, “ Business Day ”
means a day, other than a Saturday or Sunday, on which commercial banks in New York City are open for the general transaction of business.
The Company shall promptly (and in any event within one (1) Business Day) provide the Purchaser with written notice of the termination
of the Merger Agreement.

(D) Company
Discretion. The Purchaser understands and agrees that, prior to the execution and delivery of this Agreement by the Company, the
Company in its sole discretion reserves the right to accept or reject this subscription for Shares, in whole or in part. The Company
and the Purchaser shall have no obligation hereunder until the Company shall execute and deliver to the Purchaser an executed copy
of this Agreement.

1. Placement Agent. Network 1 Financial Services, Inc., a U.S.-registered broker-dealer, has been engaged as placement agent (the “ Placement Agent ” or “ Network-1 ”), on a reasonable best-efforts basis, for the Offering. The Placement Agent shall be paid at each closing from the Offering proceeds a total cash commission of 8% of funds raised from the investors in the Offering (the “ Cash Fee ”) and shall receive warrants to purchase an aggregate of a number of shares of Common Stock equal to 8% of the number of shares of Common Stock sold in the Offering (other than to Insider Investors), with a term expiring five years after the Common Stock begins to trade on Nasdaq or New York Stock Exchange, and with an exercise price of $3.00 per share (the “ Placement Agent Warrants ”). The Placement Agent Warrants shall be transferable by the holder thereof only to an affiliate of the holder unless the Common Stock is listed on a national securities exchange at the time of transfer. The Issuer has agreed to pay certain expenses of the Placement Agent in connection with the Offering.

3

1. Representations and Warranties of the Company. Except as set forth in (i) the Disclosure Schedule delivered to the Purchaser prior to or concurrently with the execution of this Agreement (the “ Disclosure Schedule ”), or (ii) the Delivered Super 8-K (as defined under Section 6(j)) delivered to the Purchaser in accordance with Section 6(j) of this Agreement (but excluding any disclosures (whether contained under the heading “Risk Factors,” in any “forward-looking statements” disclaimer or in any other section) to the extent they are cautionary, predictive or forward-looking in nature), the Company hereby represents and warrants to the Purchaser, as of the date hereof and as of each applicable Closing Date, the following (provided that, as used in this Section 3, the term “Subsidiaries” shall be construed to include Ionetix as of each applicable Closing Date and, provided, further, that representations and warranties referencing the “Delivered Super 8-K” prior to the filing of the Super 8-K with the SEC shall be deemed to be based on the assumption that the Merger has been consummated in accordance with the terms described in the Draft Super 8-K (as defined below)):

(a) Organization
and Qualification. The Company and each of its Subsidiaries is a corporation or limited liability company, as the case may be,
duly organized, validly existing and in good standing under the Laws of the jurisdiction of its incorporation or formation, and has
the requisite corporate or limited liability company power to own, lease and operate its properties and to carry on its business as
currently conducted and as described in the Delivered Super 8-K. The Company and each of its Subsidiaries is duly qualified as a
foreign corporation or limited liability company, as the case may be, to do business and is in good standing in every jurisdiction
in which the nature of the business as currently conducted and as described in the Delivered Super 8-K makes such qualification
necessary, except to the extent that the failure to be so qualified or be in good standing would not have a Material Adverse Effect.
For purposes of this Agreement, “ Material Adverse Effect ” means any event, circumstance, development,
condition, occurrence, state of facts, change or effect that, individually or in the aggregate with any other event, circumstance,
development, condition, occurrence, state of facts, change or effect, has or would reasonably be expected to (x) prevent or
materially delay or materially impair the ability of the Company or its Subsidiaries to carry out its obligations under this
Agreement or (y) have any material adverse effect on the business, properties, assets, liabilities, operations or condition
(financial or otherwise), results of operations or future prospects of the Company and its Subsidiaries, taken as a whole; provided, however,
that for purposes of clause (y), none of the following shall be deemed in themselves, either alone or in combination, to constitute,
and none of the following shall be taken into account in determining whether there has been or would reasonably be expected to have
a “Material Adverse Effect”: (i) general economic, financial, credit, capital market or regulatory conditions or any
changes therein (provided, however, that such effects do not affect the Company and its Subsidiaries taken as a whole
disproportionately as compared to the Company’s similarly-situated competitors), (ii) any effects alone or in combination that
arise out of, or result from, directly or indirectly, the announcement, pendency, execution or performance of this Agreement, the
transactions contemplated hereby or any action contemplated by this Agreement, (iii) acts of God, war (whether or not declared),
disease, including the COVID 19 pandemic, the commencement, continuation or escalation of a war, acts of armed hostility, sabotage
or terrorism or other international or national calamity or any material worsening of such conditions (provided, however,
that such changes do not affect the Company or its Subsidiaries disproportionately as compared to the Company’s
similarly-situated competitors), (iv) any matter disclosed in the Disclosure Schedule or the Delivered Super 8-K (excluding any
disclosures (whether contained under the heading “Risk Factors,” in any “forward looking statements”
disclaimer or in any other section) to the extent they are cautionary, predictive or forward-looking in nature); (v) any failure by
the Company or its Subsidiaries to meet any projections, budgets or estimates of revenue or earnings (it being understood that the
facts giving rise to such failure may be taken into account in determining whether there has been a Material Adverse Effect (except
to the extent such facts are otherwise excluded from being taken into account by this proviso)), (vi) changes affecting the industry
generally in which the Company or its Subsidiaries operate (provided, however, that such changes do not affect the
Company or its Subsidiaries disproportionately as compared to the Company’s similarly-situated competitors), or (vii) changes
in Law or U.S. generally accepted accounting principles (“ GAAP ”) (provided, however, that
such changes do not affect the Company or its Subsidiaries disproportionately as compared to the Company’s similarly-situated
competitors). For purposes of this Agreement, “ Subsidiary ” means, with respect to the Company, any
corporation, partnership, limited liability company, joint venture or other legal entity of any kind (i) of which fifty percent
(50%) or more of the capital stock or other equity interests or voting power are, directly or indirectly, controlled, owned or held
by, or (ii) that is, at the time any determination is made, controlled (whether by voting power, Contract (as defined below) or
otherwise) by, in each case, the Company (either alone or through or together with one or more of its other Subsidiaries); provided,
that for all purposes of the representations and warranties of the Company set forth in this Agreement, whether made as of the date
hereof or as of the applicable Closing Date, Ionetix and its Subsidiaries shall be deemed to be Subsidiaries of the Company
regardless of whether the Merger has been consummated.

4

(b) Authorization,
Enforcement, Compliance with Other Instruments. (i) The Company and each of its Subsidiaries party thereto has the requisite
corporate or limited liability company power and authority to enter into and perform its obligations under this Agreement, the
Registration Rights Agreement, the Escrow Agreement and the Merger Agreement (collectively with all other documents, certificates or
instruments executed and delivered in connection with the transactions contemplated hereby or thereby, the “ Transaction
Documents ”) and to consummate the transactions contemplated thereby, including to issue the Shares, in accordance with
the terms hereof and thereof; (ii) the execution and delivery by the Company and each of its Subsidiaries party thereto of each of
the Transaction Documents and the consummation by it of the transactions contemplated hereby and thereby, including, without
limitation, the issuance of the Shares, have been, or will be at the time of execution of such Transaction Document, duly authorized
by the Board of Directors or other applicable governing body of the Company or such Subsidiary, and no further action, proceeding,
consent, waiver or authorization is, or will be at the time of execution of each such Transaction Document, required by or from the
Company or any such Subsidiary, its respective board of directors or other governing body or its respective stockholders or equity
holders; (iii) this Agreement has been, and at the Closing each of the other Transaction Documents will be when delivered at the
Closing, duly executed and delivered by the Company and each of its Subsidiaries party thereto; and (iv) this Agreement and the
other Transaction Documents, when delivered at the Closing or at the closing of the Merger, as applicable, will constitute the valid
and binding obligations of the Company and its Subsidiaries party thereto enforceable against the Company and its Subsidiaries party
thereto in accordance with their terms, except as such enforceability may be limited by general principles of equity or applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement
of creditors’ rights and remedies and, with respect to any rights to indemnity or contribution contained in the Transaction
Documents, as such rights may be limited by state or federal laws or public policy underlying such laws.

(c) Capitalization.
As of the date hereof and without giving effect to the Merger, the authorized capital stock of the Company consists of 200,000,000 shares of Common Stock and there are 5,500,000 shares of Common Stock outstanding and no shares of Preferred Stock outstanding.
Immediately following the effective time of the Merger, but immediately before the Initial Closing, the authorized capital stock of
the Company will consist of 510,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock, and the Company is expected
to have 115,500,000 shares of Common Stock issued and outstanding (assuming the exchange of all Ionetix securities, as contemplated
by the Merger Agreement) and will have no shares of Preferred Stock issued and outstanding; and at the Initial Closing 10,000,000
common shares will be issued if the Minimum Offering Amount is sold and 13,333,333 common shares will be issued if the Maximum
Offering Amount is sold. (in each case including conversion in full of any SAFE Notes). All of the outstanding shares of Common
Stock and of the capital stock of each of the Company’s Subsidiaries have been duly authorized, validly issued and are fully
paid and non-assessable and free of preemptive or similar rights and other Liens. All of the issued and outstanding capital stock of
each Subsidiary of the Company are owned, directly or indirectly, by the Company, free and clear of any Liens. Immediately after
giving effect to the Merger and the Closing of the Minimum Offering Amount or the Maximum Offering Amount (in each case, assuming no
sales pursuant to the Over-Subscription Option), the pro forma outstanding capitalization of the Company will be as set forth under
“ Pro Forma Capitalization ” in Schedule 3c. Immediately after giving effect to the Merger and
the Closing: (i) no shares of capital stock of the Company or any of its Subsidiaries will be subject to preemptive rights or any
other similar rights or any Liens (as defined below) suffered or permitted by the Company; (ii) except as set forth on Schedule
3c(ii), there will be no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible, exercisable or exchangeable into, any shares of capital stock of the
Company or any of its Subsidiaries, or any Contracts by which the Company or any of its Subsidiaries is or may become bound or
pursuant to which the Company or any of its Subsidiaries is otherwise obligated to issue additional shares of capital stock of the
Company or any of its Subsidiaries; (iii) there will be no outstanding debt securities of the Company or any of its Subsidiaries
other than indebtedness as set forth in Schedule 3c(iii); (iv) other than pursuant to the Registration Rights
Agreement or as set forth in Schedule 3c(iv), there will be no agreements or arrangements under which the Company or
any of its Subsidiaries is obligated to register the sale of any of their securities under the Securities Act; (v) there will be no
outstanding registration statements of the Company or any of its Subsidiaries, other than pursuant to the Registration Rights
Agreement; (vi) except as set forth in Schedule 3c(vi), there will be no securities or instruments of the Company or
any of its Subsidiaries containing anti-dilution or similar provisions, including the right to adjust the exercise, exchange or
reset price under such securities, that will be triggered by the issuance of the Shares as described in this Agreement; (vii) no
co-sale right, right of first refusal or other similar right will exist with respect to the Shares or the issuance and sale thereof
and (viii) no shares of Common Stock shall be reserved for issuance, other than shares of Common Stock reserved for issuance upon
exercise or conversion of the securities listed in Schedule 3c(viii). The Company has made available to the Purchaser
true and correct copies of the Company’s Certificate of Incorporation, as in effect as of the Initial Closing, and the
Company’s Bylaws, as in effect as of the Initial Closing, and the terms of all securities exercisable for Common Stock and the
material rights of the holders thereof in respect thereto other than stock options issued to officers, directors, employees and
consultants. Except for the interests in the Company’s Subsidiaries, neither the Company nor any of its Subsidiaries owns any
equity interest or other interest of any nature in, or any interest convertible, exchangeable, or exercisable for, equity interests
or other interests of any nature in any other person.

5

(d) Issuance
of Shares. The Shares that are being issued to the Purchaser hereunder, when issued, sold and delivered in accordance with the terms
and upon payment of the consideration set forth in this Agreement, will be duly and validly issued, fully paid and non-assessable, and
free of preemptive or similar rights, Taxes and other Liens with respect to the issuance thereof, and restrictions on transfer other than
restrictions on transfer under the Transaction Documents, applicable state and federal securities Laws and Liens created by or imposed
by the Purchaser. Assuming the accuracy of each of the representations and warranties of the Purchaser herein, and of the Other Purchasers
in each of their respective Other Subscription Agreements, the offer, issuance and sale by the Company of the Shares to the Purchaser
is exempt from registration under the Securities Act.

(e) No
Conflicts. The execution, delivery and performance of each of the Transaction Documents by the Company, and the consummation by
the Company of the transactions contemplated hereby and thereby, including issuance and sale of the Shares in accordance with this
Agreement, have not and will not (i) result in a violation of the Certificate of Incorporation or the Bylaws (or equivalent
constitutive document) of the Company or any of its Subsidiaries; (ii) violate or conflict with, or result in a breach of any
provision of, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give
to others any rights of termination, amendment, acceleration or cancellation of, any Contract to which the Company or any Subsidiary
is a party, except for those which would not reasonably be expected to be material to the business of the Company and its
Subsidiaries, taken as a whole, or (iii) result in a violation of any Law applicable to the Company or any Subsidiary or by which
any property or asset of the Company or any Subsidiary is bound or affected, except for those which would not reasonably be expected
to be material to the business of the Company and its Subsidiaries, taken as a whole. Neither the Company nor any Subsidiary is in
violation of or in default under, any provision of its Certificate of Incorporation or Bylaws or any other constitutive documents.
Neither the Company nor any Subsidiary is in violation of any term of or in default under any Contract, judgment, decree or order or
any Law applicable to the Company or any Subsidiary, which violation or breach has been or would reasonably be expected to be
material to the business of the Company and its Subsidiaries, taken as a whole. Except as specifically contemplated by this
Agreement and as required under the Securities Act and any applicable state securities Laws, neither the Company nor any of its
Subsidiaries is required to obtain any Authorization of, or provide any notice to or make any filing or registration with, any
Governmental Authority in order for it to execute, deliver or perform any of its obligations under or contemplated by this Agreement
or the other Transaction Documents in accordance with the terms hereof or thereof, other than (i) the filings required pursuant to
Section 9 (i), (ii) the filing of the registration statement contemplated by the Registration Rights Agreement and (iii) the filing
of a Notice of Exempt Offering of Securities on Form D with the Securities and Exchange Commission (the
“ SEC ”) under Regulation D. Except as set forth on Schedule 3e, neither the execution and
delivery by the Company of the Transaction Documents, nor the consummation by the Company of the transactions contemplated hereby or
thereby, will require any notice, consent or waiver under any Contract to which the Company or any Subsidiary is a party or by which
the Company or any Subsidiary is bound or to which any of their assets or businesses is subject, except for any notice, consent or
waiver the absence of which would not reasonably be expected, individually or in the aggregate, to be material to the business of
the Company and its Subsidiaries, taken as a whole. All notices, consents, authorizations, orders, filings and registrations which
the Company or any of its Subsidiaries is required to deliver or obtain pursuant to the preceding two sentences have been or will be
delivered or obtained or effected, and shall remain in full force and effect, on or prior to the Closing.

(f) Absence
of Litigation. Except as set forth on Schedule 3f, there is no , and since the date that is two (2) years prior to the
date hereof (the “ Lookback Date ”) there has not been any, action, suit, claim, inquiry, notice of violation,
arbitration, petition, charge, citation, summons, subpoena, proceeding (including any partial proceeding such as a deposition) or investigation
of any nature, civil, criminal, administrative, regulatory or otherwise, whether at law or in equity, before or by any Governmental Authority
(an “ Action ”) pending or threatened in writing or, to the knowledge of the Company, threatened orally, against
or affecting the Company or any of its Subsidiaries or any of their respective officers or directors or any of their respective assets
or businesses, which has or would be reasonably likely to (i) adversely affect the validity or enforceability of, or the authority or
ability of the Company to perform its obligations under, this Agreement or any of the other Transaction Documents or (ii) be material
to the business of the Company and its Subsidiaries, taken as a whole. For the purpose of this Agreement, the knowledge of the Company
means the knowledge of the officers of the Company (for the avoidance of doubt, after giving effect to the Merger) and Ionetix, in each
case, both actual knowledge or knowledge that they would have had upon reasonable inquiry of the personnel of the Company or Ionetix,
as applicable responsible for the applicable subject matter. Neither the Company nor any of its Subsidiaries is, and since the Lookback
Date has not been, subject to any judgment, decree, or order which has been, or would reasonably be expected to be material to the business
of the Company and its Subsidiaries, taken as a whole.

6

(g) Acknowledgment
Regarding Purchaser’s Purchase of the Shares. The Company acknowledges and agrees that the Purchaser is acting solely in the
capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby.
The Company further acknowledges that the Purchaser is not acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by the Purchaser or
any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchaser’s purchase of the Shares.

(h) No
General Solicitation. Neither the Company, nor to its knowledge any of its Affiliates (as defined below), or any person acting on
its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection
with the offer or sale of the Shares. “ Affiliate ” means, with respect to any person, any other person that,
directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with such person, as
such terms are used in and construed under Rule 144 under the Securities Act (“ Rule 144 ”). With respect to the
Purchaser, any investment fund or managed account that is managed on a discretionary basis by the same investment manager as the Purchaser
will be deemed to be an Affiliate of the Purchaser.

(i) No
Integrated Offering. Neither the Company, nor any of its Affiliates, nor to the knowledge of the Company, any person acting on its
or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under
circumstances that would eliminate the availability of the exemption from registration under Rule 506 of Regulation D or afforded by Section
4(a)(2) of the Securities Act in connection with the Offering of the Shares contemplated hereby or cause this Offering of the Shares to
be integrated with prior offerings by the Company for purposes of the Securities Act.

(j) Employee
Relations. Since the Lookback Date, there has been no actual or threatened in writing, or to the knowledge of the Company,
threatened orally, labor dispute, work stoppage, request for representation, union organizing activity, or unfair labor practice
charges involving the employees of the Company or any of its Subsidiaries. Neither the Company nor any Subsidiary is party to any
collective bargaining agreement. The Company’s and/or its Subsidiaries’ employees are not members of any union, and the
Company believes that its and its Subsidiaries’ relationships with their respective employees are good.

7

(k) Intellectual
Property Rights. Except as set forth on Schedule 3k, the Company and each of its Subsidiaries exclusively owns,
possesses, or has valid and enforceable rights to use, license, and exploit all Intellectual Property used in, necessary or
advisable for the conduct of the Company’s and its Subsidiaries’ business as currently conducted and as described in the
Delivered Super 8-K, except for a failure to own, possess or have such rights that would not reasonably be expected to result in a
Material Adverse Effect. There are no unreleased liens or security interests which have been filed, or which the Company has
received notice of, against any of the Intellectual Property owned by the Company. All Intellectual Property owned by the Company or
its Subsidiaries, and all Contracts pursuant to which the Company or its Subsidiaries license Intellectual Property, are valid and
enforceable, and the Company and its Subsidiaries are in full compliance with all such Contracts except as would not reasonably be
expected to result in a Material Adverse Effect. Furthermore, except as has not been and would not reasonably be expected to result
in a Material Adverse Effect, since the Lookback Date: (A) to the Company’s knowledge, there has been no infringement,
misappropriation or violation by third parties of any such Intellectual Property of the Company or its Subsidiaries; (B) there has
been no Action pending or threatened in writing (or to the Company’s knowledge, threatened orally) by others challenging the
Company’s or any of its Subsidiaries’ ownership of or any rights in or to any such Intellectual Property; (C) the
Intellectual Property owned by the Company and its Subsidiaries and, to the Company’s knowledge, the Intellectual Property
licensed to the Company and its Subsidiaries, has not been adjudged invalid or unenforceable, in whole or in part, and there has
been no Action pending or threatened in writing (or to the Company’s knowledge, threatened orally) by others challenging the
validity, enforceability or scope of any such Intellectual Property; (D) there has been no Action pending or threatened in writing
(or to the Company’s knowledge, threatened orally) by others that the Company or any of its Subsidiaries infringes,
misappropriates or otherwise violates any Intellectual Property or other proprietary rights of others, and neither the Company nor
any of its Subsidiaries has received any written notice of such Action; and (E) to the Company’s knowledge, no employee of the
Company or any of its Subsidiaries has violated any term of any employment Contract, patent disclosure agreement, invention
assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or restrictive covenant to or
with a former employer where the basis of such violation relates to such employee’s employment with the Company or any of its
Subsidiaries or actions undertaken by the employee while employed with the Company or any of its Subsidiaries. Except as would not
reasonably be expected to have a Material Adverse Effect, the Company and its Subsidiaries have complied in all material respects
with 37 C.F.R. § 1.56 (Duty to disclose information material to patentability). The consummation of the transactions
contemplated hereby or by the other Transaction Documents will not result in the loss or impairment of or payment of any additional
amounts with respect to, nor require the consent of any other person in respect of, the Company or any of its Subsidiaries’
right to own, use or hold for use any Intellectual Property as owned, used or held for use in the conduct of the Company’s and
its Subsidiaries’ business as currently conducted and as described in the Delivered Super 8-K, except as would not reasonably
be expected to be material to the business of the Company and its Subsidiaries, taken as a whole. The rights of the Company and each
of its Subsidiaries in their Intellectual Property are valid, subsisting and enforceable, except as would not reasonably be expected
to be material to the business of the Company and its Subsidiaries, taken as a whole. The Company and each of its Subsidiaries has
taken reasonable steps to maintain their Intellectual Property and to protect and preserve the confidentiality of all of their Trade
Secrets. To the Company’s knowledge, there has not been any disclosure or access to any Trade Secrets of the Company and each
of its Subsidiaries by any unauthorized person. The Company and each of its Subsidiaries have taken and continue to take
commercially reasonable measures, at least consistent with prevailing industry practice, to ensure that all personal information in
their possession, custody or control is protected against loss and against unauthorized, access, use, modification, disclosure or
other misuse. “ Intellectual Property ” shall mean any and all rights title and interest in, arising out of,
or associated with any intellectual or intangible property, whether protected, created or arising in any jurisdiction throughout the
world, including the following: (a) issued patents and patent applications (whether provisional or non-provisional), including
divisionals, continuations, continuations-in-part, substitutions, reissues, reexaminations, extensions, or restorations of any of
the foregoing, and other Governmental Authority (as defined below) issued indicia of invention ownership (including certificates of
invention, petty patents, and patent utility models) (“ Patents ”); (b) trademarks, service marks, brands,
certification marks, logos, trade dress, slogans, trade names, and other similar indicia of source or origin, together with the
goodwill connected with the use of and symbolized by, and all registrations, applications for registration, and renewals of, any of
the foregoing (“ Trademarks ”); (c) copyrights and works of authorship, whether or not copyrightable, and
all registrations, applications for registration, and renewals of any of the foregoing (“ Copyrights ”); (d)
internet domain names and social media account or user names (including “ handles ”), whether or not
Trademarks, all associated web addresses, URLs, websites and web pages, social media sites and pages, and all content and data
thereon or relating thereto, whether or not Copyrights; (e) mask works, and all registrations, applications for registration, and
renewals thereof; (f) industrial designs, and all Patents, registrations, applications for registration, and renewals thereof; (g)
trade secrets, know-how, inventions (whether or not patentable), discoveries, improvements, technology, business and technical
information, databases, data compilations and collections, tools, methods, processes, techniques, and other confidential and
proprietary information and all rights therein (“ Trade Secrets ”); (h) computer programs, operating
systems, applications, firmware and other code, including all source code, object code, application programming interfaces, data
files, databases, protocols, specifications, and other documentation thereof; (i) rights of publicity; and (j) all other
intellectual or industrial property and proprietary rights.

8

| | (l) | Environmental Laws. |

(i) Except
as, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect: (x) the Company
and each Subsidiary is in compliance and has complied with all applicable Environmental Laws (as defined below); (y) the Company or its
applicable Subsidiary is in possession of all Authorizations required pursuant to Environmental Laws to conduct their respective businesses
as currently conducted and as described in the Delivered Super 8-K and (z) the Company or its applicable Subsidiary is in material compliance
with all terms and conditions of such Authorizations. There is no Action pending or threatened in writing (or to the Company’s knowledge,
threatened orally) relating to any violation or noncompliance with any Environmental Law involving the Company or any Subsidiary, except
for litigation, notices of violations, formal administrative proceedings or investigations, inquiries or information requests that, individually
or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect. For purposes of this Agreement,
“ Environmental Law ” means any national, state, provincial or local Law, statute, rule or regulation or the common
law relating to the environment or occupational health and safety, including without limitation any statute, regulation, administrative
decision or order pertaining to (A) treatment, storage, disposal, generation and transportation of Hazardous Substances; (B) air, water
and noise pollution; (C) groundwater and soil contamination; (D) the release or threatened release into the environment of industrial,
toxic or hazardous materials or substances, or solid or hazardous waste, including without limitation emissions, discharges, injections,
spills, escapes or dumping of pollutants, contaminants or chemicals; (E) the protection of wild life, marine life and wetlands, including
without limitation all endangered and threatened species; (F) storage tanks, vessels, containers, abandoned or discarded barrels, and
other closed receptacles; (G) health and safety of employees and other persons; and (H) manufacturing, processing, using, distributing,
treating, storing, disposing, transporting or handling of Hazardous Substances. As used above, the terms “release” and “environment”
shall have the meaning set forth in the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended.

(ii) To
the knowledge of the Company, none of the Company or any of its Subsidiaries has any liability or obligation under any Environmental Law
with respect to any release, spill, emission, leaking, pumping, pouring, emptying, leaching, escaping, dumping, injection, deposit, discharge
or disposing of any Hazardous Substance in, onto or through the environment, except as would not reasonably be expected to have a Material
Adverse Effect. “ Hazardous Substances ” means all materials, wastes, or substances defined by, or regulated under,
any Environmental Laws, including as a hazardous waste, hazardous material, hazardous substance, extremely hazardous waste, restricted
hazardous waste, contaminant, pollutant, toxic waste, or toxic substance, and specifically including petroleum and petroleum products,
asbestos, radon, lead, toxic mold, radioactive materials, and polychlorinated biphenyls.

9

(m) Authorizations;
Regulatory Compliance. Except as set forth on Schedule 3m, the Company and each of its Subsidiaries holds, and is
operating in compliance with, all authorizations, licenses, permits, approvals, clearances, registrations, exemptions, consents,
certificates, waivers, filings, qualifications and orders of each applicable entity or body exercising executive, legislative,
judicial, regulatory or administrative functions of or pertaining to United States federal, state or local government or foreign, or
other governmental, including any department, commission, board, agency, bureau, official or other regulatory, administrative or
judicial or arbitral authority thereto (each a “ Governmental Authority ”) and supplements and amendments
thereto (collectively, “ Authorizations ”) required for the conduct of its business as currently conducted
and as described in the Delivered Super 8-K, or that are otherwise material to the business of the Company and its Subsidiaries, in
all applicable jurisdictions, except as would not reasonably be expected to be material to the business of the Company and its
Subsidiaries, taken as a whole. All Authorizations held by the Company or its Subsidiaries are valid and in full force and effect.
Neither the Company nor any of its Subsidiaries is in material violation of any terms of any such Authorizations; and neither the
Company nor any of its Subsidiaries has received written notice from any Governmental Authority of any revocation or modification of
any such Authorization, or written notice (or to the Company’s knowledge, oral notice) that such revocation or modification is
being considered, except to the extent that any such revocation or modification would not be reasonably expected to be material to
the business of the Company and its Subsidiaries, taken as a whole. The Company and each of its Subsidiaries is in compliance, and
has since the Lookback Date been in compliance, with all applicable federal, state, local and foreign Laws, including such Laws
applicable to the manufacture, distribution, import and export of regulated products and component parts, except as would not
reasonably be expected to be material to the business of the Company and its Subsidiaries, taken as a whole. Neither the Company nor
any of its Subsidiaries has received written notice (or to the Company’s knowledge, oral notice) of any ongoing claim, action,
suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental Authority or third party
alleging that any product operation or activity is in material violation of any Laws or any Authorizations. The Company and each of
its Subsidiaries has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications,
records, claims, submissions and supplements or amendments thereto as required by any Laws or any Authorizations and all such
reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments, to the Company’s
knowledge, were complete, correct and not misleading on the date filed in all material respects (or were corrected or supplemented
by a subsequent submission). Neither the Company nor any of its Subsidiaries is a party to any corporate integrity agreement,
deferred prosecution agreement, monitoring agreement, consent decree, settlement order, or similar agreements, or has any reporting
obligations pursuant to any such agreement, plan or correction or other remedial measure entered into with any Governmental
Authority.

(n) Title.
Neither the Company nor any of its Subsidiaries owns any real property. Except as set forth on Schedule 3n, each of the
Company and its Subsidiaries has good and marketable title to all of its personal property and other tangible assets (i) purportedly owned
or used by them as reflected in the Delivered Super 8-K, or (ii) necessary for the conduct of their business as currently conducted and
as described in the Delivered Super 8-K, free and clear of any legal or equitable, specific or floating, lien (statutory or otherwise),
restriction, mortgage, deed of trust, pledge, lien, security interest, restrictive covenant, or other adverse right, charge, claim or
encumbrance of any kind or nature whatsoever (collectively, “ Liens ”), except for Liens which would not reasonably
be expected to have a Material Adverse Effect. Except as set forth on Schedule 3n, with respect to properties and assets
it leases, each of the Company and its Subsidiaries is in compliance with such leases and holds a valid leasehold interest free of any
Liens, except for such Liens which would not reasonably be expected to have a Material Adverse Effect.

10

(o) Tax
Status. The Company and each Subsidiary has filed (taking into account any valid extensions) all federal, state, local and
foreign income and all other material returns, declarations, reports, elections, designations, or information returns or statements
made to a Governmental Authority relating to Taxes, including any schedules or attachments thereto and any amendments thereof
(collectively, “ Tax Returns ”) required to be made or filed by it or with respect to it by any jurisdiction
to which it is subject. Such Tax Returns accurately reflect, in all material respects, the Tax liabilities of the Company and its
Subsidiaries (other than Taxes not yet due and payable). The Company and each Subsidiary has timely paid all income Taxes and all
other material Taxes and other material governmental assessments and material charges, shown or determined to be due on such
returns, reports and declarations, except those being contested in good faith and for which the Company and its Subsidiaries have
adequately reserved and accrued for in accordance with GAAP. The Company has reserved and accrued on its books provisions in
accordance with GAAP amounts that are reasonably adequate for the payment of all material taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. There are no unpaid Taxes in any material amount claimed to be due
from the Company or any Subsidiary by the taxing authority of any jurisdiction. There are no, and since the Lookback Date there have
been no, pending or threatened in writing (or to the Company’s knowledge, threatened orally) Actions by the taxing authority
of any jurisdiction against the Company or any of its Subsidiaries. Neither the Company nor any of its Subsidiaries is a party to,
or otherwise bound by, any Tax indemnity, Tax sharing or Tax allocation agreement (but not including any agreement whose primary
subject matter is not Taxes) (a “ Tax Agreement ”). The Company is not a “United States real property holding
corporation” within the meaning of Section 897(c) of the Code. For purposes of this Agreement, “ Tax ”
or “ Taxes ” means (i) any and all U.S. federal, state, local, or non-U.S. taxes, assessment, levy or other
charges, including net or gross income, gross receipts, net proceeds, estimated, sales, use, ad valorem, value added, franchise,
license, withholding, payroll, employment, excise, property (including both real and personal), unclaimed property
remittance/escheat, deed, stamp, alternative or add-on minimum, occupation, severance, unemployment, social security, workers’
compensation, capital, premium, windfall profit, environmental, custom duties, fees, transfer and registration taxes, and any
governmental charges in the nature of a tax imposed by a Governmental Authority, (ii) any liability for the payment of any amounts
of any of the foregoing types as a result of being a member of an affiliated, consolidated, combined or unitary group, or being a
party to any agreement or arrangement whereby liability for payment of such amounts was determined or taken into account with
reference to the liability of any other person and (iii) any liability for the payment of any amounts as a result of being a party
to any Tax Agreement.

(p) Certain
Transactions. Except as set forth on Schedule 3p, none of the direct or indirect equity holders, stockholders, controlling
persons, partners, managers, members, officers, directors, employees, general or limited partners or assignees (each, a “ Related
Party ”) of the Company or any Subsidiary is presently, or has since the Lookback Date been, a party to any Contract or transaction
with the Company or any Subsidiary (other than for services as employees, officers and directors and for the purchase of shares of the
Company’s capital stock and the issuance of options to purchase shares of the Company’s Common Stock), including any Contract
providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring
payments to or from any officer, director or such employee or, to the knowledge of the Company, any corporation, partnership, trust or
other entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner.
All transactions that would be required to be disclosed by the Company pursuant to Item 404 of Regulation S-K promulgated under the Securities
Act are disclosed in the SEC Reports (as defined below) or the Delivered Super 8-K in accordance with Item 404 of Regulation S-K.

(q) Rights
of First Refusal. Except as set forth on Schedule 3q, the Company is not obligated to offer the securities offered hereunder
on a right of first refusal basis or otherwise to any third parties including, but not limited to, current or former stockholders of the
Company, underwriters, brokers, agents or other third parties.

(r) Insurance.
The Company and its Subsidiaries have insurance policies of the type and in amounts customarily carried by organizations conducting businesses
or owning assets similar to those of the Company and its Subsidiaries, and in any event maintain insurance policies in amounts as required
by applicable Law or any Contract to which the Company or its Subsidiaries is a party or to which any of its assets or businesses is subject.
All such insurance policies are in full force and effect and binding and enforceable in accordance with their terms, and all premiums
due and payable thereon have been timely paid in full. Neither the Company nor any of its Subsidiaries is in default with respect to its
obligations under any such insurance policy, nor has there been any failure to give any notice or present any claim under any such insurance
policy in due and timely fashion except as would not, individually or in the aggregate, reasonably be expected to be material to the business
of the Company and its Subsidiaries, taken as a whole. There is no material claim pending under any such policy as to which coverage has
been questioned, denied or disputed by the underwriter of such policy and there has been no notice of cancellation of nonrenewal of any
such insurance policy received by the Company or any of its Subsidiaries. Since the Lookback Date, no limits on any insurance policy of
the Company or any of its Subsidiaries have been exhausted, materially eroded or materially reduced.

11

(s) SEC
Reports. The Company has timely filed or furnished , as applicable, all reports, proxy statements, schedules, forms, statements, certifications
and other documents (including exhibits and all other information incorporated by reference therein) required to be filed or furnished
by the Company under the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (the “ Exchange
Act ”) (the “ SEC Reports ”) since the Lookback Date (or such shorter period since the Company was
first required by Law or regulation to file such material). The Super 8-K when filed will comply, and the SEC Reports at the time they
were filed complied, in all material respects with the Securities Act or the Exchange Act, as applicable. There are no Contracts (or any
material change or amendment thereto, or any waiver of any material right thereunder) that are required to be described in the SEC Reports
or the Delivered Super 8-K that were or are not described, in all material respects, therein. There are no Contracts (or any material
change or amendment thereto, or any waiver of any material right thereunder) that are required to be filed as exhibits to the SEC Reports
or the Super 8-K that were not or will not have been filed as required in the SEC Reports or the Super 8-K. There are no outstanding or
unresolved comments in comment letters received from the SEC staff with respect to the SEC Reports. To the Company’s knowledge,
none of the SEC Reports is the subject of an ongoing SEC review. There are no SEC inquiries or investigations, other governmental inquiries
or investigations or internal investigations pending or threatened in writing (or, to the Company’s knowledge, threatened orally),
in each case regarding any accounting practice of the Company.

| | (t) | Financial Statements. |

(i) The
audited consolidated financial statements of Ionetix and its Subsidiaries as of and for the fiscal years ended December 31, 2025 and 2024,
(in each case consisting of the balance sheets, related statements of operations, changes in stockholders’ equity (deficit) and
cash flows), and any unaudited pro forma consolidated financial statements of the Company (after taking into effect the Merger) (including,
in each case, the notes thereto) included in the Delivered Super 8-K comply in all material respects with GAAP and the rules and regulations
of the SEC with respect thereto as in effect at the time of filing (the foregoing financial statements, the “ Financial Statements ”).
The Financial Statements have been prepared in accordance with GAAP applied on a consistent basis during the periods involved and include
all adjustments (consisting only of normal recurring accruals) that are necessary for a fair presentation of the consolidated financial
condition of the business to which they relate as of the date thereof, subject, to normal year-end adjustments that will not, individually
or in the aggregate, be material and the absence of notes, and fairly present in all material respects the financial position of Ionetix
and its Subsidiaries taken as a whole, or the Company and its consolidated Subsidiaries taken as a whole, as applicable, as of and for
the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements,
to normal, year-end audit adjustments that will not, individually or in the aggregate, be material. The pro forma financial information
and the related notes, if any, included in the Delivered Super 8-K have been properly compiled and prepared in accordance with the applicable
requirements of the Securities Act and fairly present in all material respects the information shown therein, and the assumptions used
in the preparation thereof are reasonable and the adjustments used therein are appropriate to give effect to the transactions and circumstances
referred to therein.

(ii) Except
as disclosed in the Delivered Super 8-K, the Company (A) maintains a standard system of accounting established and administered in accordance
with GAAP and (B) has established and maintains a system of internal controls over financial reporting designed to provide reasonable
assurance regarding the reliability of the financial reporting and the preparation of the Financial Statements for external purposes in
accordance with GAAP. There (x) are no significant deficiencies or material weaknesses in any system of internal accounting controls used
by each of the Company’s Subsidiaries, except as disclosed in the Delivered Super 8-K, (y) has not since the Lookback Date been
any fraud or other unlawful act on the part of any of management or other employees of the Company and each of its Subsidiaries who have
a role in the preparation of Financial Statements or the internal accounting controls used by the Company and each of its Subsidiaries
related to such preparation or controls and (z) has not since the Lookback Date been any claim or allegation regarding any of the foregoing.

(iii) Neither
the Company nor any of its Subsidiaries has any liabilities (whether accrued, absolute, contingent or otherwise) other than (A) liabilities
disclosed on the audited balance sheet (including the notes thereto) or the interim balance sheet (including the notes thereto) and (B)
liabilities that have been incurred since the date of the latest balance sheet of the Company and the latest balance sheet of Ionetix
included in the Financial Statements in the ordinary course of business, which liabilities, individually or in the aggregate, are not
material to the business of the Company and its Subsidiaries (taken as a whole).

12

(iv) To
the knowledge of the Company, M&K CPAs, PLLC (the “ Auditor ”), whose report will be filed with the SEC and
included in the Super 8-K, is an independent registered public accounting firm with respect to the Company as required by the Exchange
Act and the rules and regulations promulgated thereunder and the rules and regulations of the Public Company Accounting Oversight Board.
The Auditor has not, during the periods covered by the Financial Statements provided to the Company any non-audit services, as such term
is used in Section 10A(g) of the Exchange Act.

(u) Material
Changes. Except for the transactions contemplated hereby or in the Merger Agreement, since the date of the latest balance sheet
of the Company and the latest balance sheet of Ionetix included in the financial statements contained in the Delivered Super 8-K,
except as set forth on Schedule 3(u), (i) there have been no events, occurrences or developments that have had or
would reasonably be expected to have a Material Adverse Effect with respect to the Company or Ionetix, (ii) there have not been any
changes in the assets, financial condition, business or operations of the Company or Ionetix from that reflected in the financial
statements contained in the Delivered Super 8-K except changes in the ordinary course of business which have not been, either
individually or in the aggregate, materially adverse to the business, properties, financial condition, results of operations or
future prospects of the Company or Ionetix, (iii) none of the Company or Ionetix or any of their respective Subsidiaries has altered
its method of accounting or the manner in which it keeps its accounting books and records, and (iv) none of the Company or Ionetix
or any of their respective Subsidiaries has declared or made any dividend or distribution of cash or other property to its
stockholders or equity holders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock
(other than in connection with repurchases of unvested stock issued to employees of the Company). The Company and its Subsidiaries,
individually and on a consolidated basis, are not as of the date hereof, and after giving effect to the transactions contemplated
hereby to occur at the Initial Closing, will not be Insolvent (as defined below). “ Insolvent ” means, with
respect to the Company, on a consolidated basis with its Subsidiaries, (i) the present fair saleable value of the Company’s
and its Subsidiaries’ assets is less than the amount required to pay the Company’s and its Subsidiaries’ total
indebtedness, (ii) the Company and its Subsidiaries are unable to pay their debts and liabilities, subordinated, contingent or
otherwise, as such debts and liabilities become absolute and matured or (iii) the Company and its Subsidiaries intend to incur or
believe that they will incur debts that would be beyond their ability to pay as such debts mature.

(v) Disclosure
Controls. The Company has established and maintains disclosure controls and procedures (as defined in Rules 13a-14 and 15d-15 under
the Exchange Act) and except as disclosed in the Delivered Super 8-K, such controls and procedures are effective in ensuring that material
information relating to the Company, including its Subsidiaries, is made known to the principal executive officer and the principal financial
officer.

(w) Sarbanes-Oxley.
The Company is, and has been since the Lookback Date, to the extent applicable, in compliance in all material respects with all of the
provisions of the Sarbanes-Oxley Act of 2002 which are applicable to it.

(x) Off-Balance
Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any Subsidiary and an unconsolidated
or other off-balance sheet entity that is required to be disclosed by the Company in the Delivered Super 8-K and is not so disclosed.

(y) Foreign
Corrupt Practices. Neither the Company and its Subsidiaries, nor any of their respective directors, managers, officers, agents or
employees or other person acting on behalf of the Company or its Subsidiaries, has: (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment or offered anything of value to foreign or domestic government officials or employees or to any foreign or domestic political
parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any of its Subsidiaries
(or, to the Company’s knowledge, made by any person acting on their behalf) which is in violation of Law or (iv) violated any applicable
anti-terrorism Law or regulation, nor have any of them otherwise taken any action which would reasonably cause the Company or any of its
Subsidiaries to be in violation of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable Law of similar effect.

13

(z) Office
of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, manager, officer,
agent, employee or Affiliate of the Company or any Subsidiary is, or is acting under the direction of, on behalf of or for the benefit
of a person that is, or is owned or controlled by a person that is, currently subject to any U.S. sanctions administered by the Office
of Foreign Assets Control of the U.S. Treasury Department.

(aa) Money
Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, and other
applicable money laundering Laws and applicable rules and regulations thereunder (collectively, the “ Money Laundering Laws ”),
and no Action by or before any Governmental Authority involving the Company or any Subsidiary with respect to the Money Laundering Laws
is pending or threatened in writing (or to the Company’s knowledge, threatened orally).

(bb) Regulation
M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any
action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of,
any of the Securities, or (iii) paid or agreed to pay to any person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection
with the placement of the Shares.

(cc) Privacy and Data Security.

(i) “ Business
Privacy and Data Security Policies ” means all of the Company’s or one of its Subsidiaries’ present, internal
or public-facing policies, notices, and statements concerning the privacy, security, or Processing of Personal Information in the conduct
of the Business. “ Personal Information ” means any information that identifies or, alone or in combination with
any other information, could reasonably be used to identify, locate, or contact a natural person, including name, street address, telephone
number, email address, identification number issued by a Governmental Authority, credit card number, bank information, customer or account
number, online identifier, device identifier, IP address, browsing history, search history, or other website, application, or online activity
or usage data, location data, biometric data, medical or health information, or any other information that is considered “personally
identifiable information,” “personal information,” or “personal data” under applicable Law, and all data
associated with any of the foregoing that are or could reasonably be used to develop a profile or record of the activities of a natural
person across multiple websites or online services, to predict or infer the preferences, interests, or other characteristics of a natural
person, or to target advertisements or other content to a natural person. “ Privacy Laws ” means all applicable
Laws, orders, writs, judgments, injunctions, decrees, stipulations, determinations or awards entered by or with any Governmental Authority,
and binding guidance issued by any Governmental Authority concerning the privacy, security, or Processing of Personal Information (including
Laws of jurisdictions where Personal Information was collected), including, as applicable, data breach notification Laws, consumer protection
Laws, Laws concerning requirements for website and mobile application privacy policies and practices, Social Security number protection
Laws, data security Laws, and Laws concerning email, text message, or telephone communications. Without limiting the foregoing, Privacy
Laws include the Health Insurance Portability and Accountability Act of 1996, as amended and supplemented by the Health Information Technology
for Economic and Clinical Health Act of the American Recovery and Reinvestment Act of 2009 and all other similar international, federal,
state, provincial, and local Laws. “ Processing ” means any operation performed on Personal Information, including
the collection, creation, receipt, access, use, handling, compilation, analysis, monitoring, maintenance, storage, transmission, transfer,
protection, disclosure, destruction, or disposal of Personal Information.

(ii) The
Company and each of its Subsidiaries, and, to the Company’s knowledge, all vendors, processors, or other third parties acting for
or on behalf of the Company or any of its Subsidiaries in connection with the Processing of Personal Information or that otherwise have
been authorized to have access to Personal Information in the possession or control of the Company or any of its Subsidiaries, comply
and at all times since the Lookback Date have complied, with all of the following in the conduct of its business as currently conducted
and as disclosed in the Delivered Super 8-K: (A) Privacy Laws; (B) rules of self-regulatory organizations; (C) industry standards, guidelines,
and best practices; (D) the Business Privacy and Data Security Policies; and (E) all obligations or restrictions concerning the privacy,
security, or Processing of Personal Information under any Contract to which the Company or any of its Subsidiaries is a party or otherwise
bound as of the date hereof, in each case, except for violations that, individually or in the aggregate, have not been and would not reasonably
be expected to be material to the business of the Company and its Subsidiaries, taken as a whole.

14

(iii) Neither
the consummation of the Merger nor the execution, delivery and performance of this Agreement and the consummation of the transactions
contemplated hereby, does or will: (A) conflict with or result in a violation or breach of any Privacy Laws or Business Privacy and Data
Security Policies (as currently existing or as existing at any time during which any Personal Information was collected or Processed by
or for the Company or any of its Subsidiaries in the conduct of its business as now being conducted); or (B) require the consent of or
notice to any person concerning such person’s Personal Information, in each case, except as has not been and would not reasonably
be expected to have a Material Adverse Effect.

(iv) Since the
Lookback Date, (A) to the Company’s knowledge, no Personal Information in the possession or control of the Company or any of its
Subsidiaries, or held or Processed by any vendor, processor, or other third party for or on behalf of the Company or any of its Subsidiaries,
in the conduct of its business has been subject to any data or security breach or unauthorized access, disclosure, use, loss, denial
or loss of use, alteration, destruction, compromise, or Processing (a “ Security Incident ”), and (B) neither
the Company nor any of its Subsidiaries has notified and, to the Company’s knowledge, there have been no facts or circumstances
that would require the Company or any of its Subsidiaries to notify, any Governmental Authority or other person of any Security Incident
in the conduct of its business, in each case, except as has not been and would not reasonably be expected to have a Material Adverse
Effect.

(v) Since
the Lookback Date, neither the Company nor any of its Subsidiaries has received any notice, request, claim, complaint, correspondence,
or other communication in writing (or to the Company’s knowledge, orally) from any Governmental Authority or other person, and to
the Company’s knowledge there has not been any audit, investigation, enforcement action (including any fines or other sanctions),
or other Action relating to, any actual, alleged, or suspected Security Incident or violation of any Privacy Law involving Personal Information
in the possession or control of the Company or any of its Subsidiaries, or held or Processed by any vendor, processor, or other third
party for or on behalf of the Company or any of its Subsidiaries, in the conduct of its business, in each case, except as has not been
and would not reasonably be expected to be material to the business of the Company and its Subsidiaries, taken as a whole.

(vi) In
the conduct of its business, the Company and each of its Subsidiaries has at all times since the Lookback Date implemented and maintained,
and required all vendors, processors, and other third parties that Process any Personal Information for or on behalf of the Company or
any of its Subsidiaries to implement and maintain, all security measures, plans, procedures, controls, and programs, including written
information security programs, to (A) identify and address internal and external risks to the privacy and security of Personal Information
in their possession or control; (B) implement, monitor, and improve adequate and effective administrative, technical, and physical safeguards
to protect such Personal Information and the operation, integrity, and security of its software, systems, applications, and websites involved
in the Processing of Personal Information; and (C) provide notification in compliance with applicable Privacy Laws in the case of any
Security Incident, in each case, except as has not been and would not reasonably be expected to be material to the business of the Company
and its Subsidiaries, taken as a whole.

(dd) Brokers’
Fees. Except as set forth on Schedule 3(dd), neither of the Company nor any of its Subsidiaries has any liability or
obligation to pay any fees or commissions to any broker, finder or agent with respect to the transactions contemplated by this Agreement,
except for the payment of fees and expenses to the Placement Agent and issuance of the Placement Agent Warrants as described in Section
2 above.

(ee) Disclosure
Materials. The SEC Reports and the Disclosure Materials, at the time filed or furnished, were (or in the case of the Super 8-K, will
be) true and correct in all material respects and did not or will not contain an untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which
they were made, not misleading. For the purposes of this Agreement, “ Disclosure Materials ” means the Confidential
and Non-Binding Summary Term Sheet of the Company previously provided to the Purchaser, and any roadshow presentation delivered to the
Purchaser in connection with the contemplated purchase of the Shares, each as amended from time to time, relating to the Offering and
any supplement or amendment thereto, and any disclosure schedule or other information document, including the Disclosure Schedule, delivered
to the Purchaser prior to its execution of this Agreement, and any such document delivered to the Purchaser after its execution of this
Agreement and prior to the closing of the Purchaser’s subscription hereunder, including the Delivered Super 8-K.

15

(ff) Investment
Company. The Company is not required to be registered as, and is not an Affiliate of, and immediately following the Closing will not
be required to register as, an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

(gg) Reliance.
The Company acknowledges that the Purchaser is relying on the representations and warranties (as modified by the disclosures on the
Disclosure Schedule or the Delivered Super 8- K (excluding any disclosures (whether contained under the heading “Risk
Factors,” in any “forward-looking statements” disclaimer or in any other section) to the extent they are
cautionary, predictive or forward-looking in nature) made by the Company hereunder and that such representations and warranties (as
modified by the Disclosure Schedule or the Delivered Super 8-K (excluding any disclosures (whether contained under the heading
“Risk Factors,” in any “forward-looking statements” disclaimer or in any other section) to the extent they
are cautionary, predictive or forward-looking in nature) are a material inducement to the Purchaser purchasing the Shares. The
Company further acknowledges that without such representations and warranties of the Company made hereunder, the Purchaser would not
enter into this Agreement with the Company.

(hh) Bad Actor
Disqualification. No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “ Disqualification
Event ”) is applicable to the Company or, to the Company’s knowledge, any Company Covered Person, except for a Disqualification
Event as to which Rule 506(d)(2)(ii–iv) or (d)(3), is applicable. “ Company Covered Person ” means, with
respect to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities Act, any person listed in
the first paragraph of Rule 506(d)(1). The Company represents that it has exercised reasonable care to determine the accuracy of the representation
made by the Company in this paragraph.

(ii) Anti-Dilution.
There are no securities or instruments issued by or to which the Company is a party as of the date hereof or as of the Closing containing
anti-dilution or similar provisions that will be triggered by the issuance of shares of Common Stock in connection with the Offering or
pursuant to any other Subscription Agreement entered into in connection with the Offering that have not been or will not be validly waived
on or prior to each Closing Date.

(jj) Other Purchasers.
The Company has not entered into any side letter or similar agreement with any Other Purchaser in connection with such Other Purchaser’s
direct or indirect investment in the Company other than the applicable Other Subscription Agreement. Each Other Purchaser will enter into
the applicable Other Subscription Agreement and no other side letters or similar agreements with respect to its investment in the shares
of Common Stock in connection with the Offering. Each Other Subscription Agreement is in the same form and contains the same terms and
provisions as this Agreement.

(kk) Leased
Real Property. There are no pending or, to the knowledge of the Company, any threatened condemnation proceedings, lawsuits or other
Actions relating to any real property leased by the Company or any of its Subsidiaries or any of the buildings, structures and facilities
located thereon (the “ Leased Real Property ”) or other matters affecting adversely the current use, occupancy
or value thereof. The Company and its applicable Subsidiaries enjoy quiet possession under all leases for each parcel of Leased Real Property
(each, a “ Lease ”) and no Leased Real Property under any such Lease is subject to any Lien, easement, right-of-way,
building or use restriction, exception, variance, reservation or limitation, as might, in any material respect, interfere with or impair
the present and continued use thereof by the Company or its Subsidiaries in the usual and normal conduct of the business of the Company
and its Subsidiaries.

(ll) Material
Contracts. Each Material Contract (as defined below) is the legal, valid and binding obligation of the Company or one of its
Subsidiaries that is a party thereto, and is enforceable against the Company or one of its Subsidiaries, as applicable, and, to the
knowledge of the Company, the counterparties, in accordance with its terms, other than, in all cases, Material Contracts that have
expired, been terminated or superseded in accordance with their terms following the date hereof. Neither the Company or any of its
Subsidiaries, nor to the knowledge of the Company, any counterparty, is in violation, breach or default under any such Contract or
has improperly terminated, revoked or accelerated any Material Contract and no event or condition exists or has occurred which, with
the giving of notice or the lapse of time or both, would, under any Material Contract, (A) constitute a breach or default by the
Company or any of its Subsidiaries, or to the knowledge of the Company, a counterparty, (B) give to the counterparty any rights of
termination, acceleration or cancellation of, (C) result in any obligation imposed on the Company or any of its Subsidiaries
thereunder or a loss of a benefit in favor of the Company or any of its Subsidiaries thereunder, (D) allow the imposition of any
fees or penalties on the Company or any of its Subsidiaries thereunder, require the offering or making of any payment or redemption
by the Company or any of its Subsidiaries thereunder or (E) give rise to any increased, guaranteed, accelerated or additional rights
or entitlements to the counterparty thereunder, in each case, except for (i) such breaches, defaults and events which would not
reasonably be expected to have a Material Adverse Effect, and (ii) any Material Contracts that will expire or terminate in
accordance with their terms in connection with or as contemplated by or directly related to the Merger Agreement and the
transactions contemplated thereby, including to the extent applicable, Contracts with the stockholders or investors of the Company
or any of its Subsidiaries, indemnification agreements with each of their respective directors or officers, employment, consulting
agreements or equity award agreements with each of their employees or other service providers. None of the Company or any of its
Subsidiaries has received any written notice of the intention of any person to terminate, fail to renew or materially and adversely
modify any Material Contract.

16

As used herein,
“ Material Contract ” means any written or oral agreement, contract, commitment, arrangement, subcontract, license,
sublicense, lease, sublease, sales order, purchase order, indenture, mortgage, note, bond, letter of credit, warrant, instrument, obligation,
or understanding (collectively, including all amendments, supplements and modifications thereto, “ Contracts ”)
to which the Company or any of its Subsidiaries is a party or by which any of their respective assets or businesses are bound:

(i) that
is required to be filed pursuant to Item 601(b)(10) of Regulation S-K promulgated under the Securities Act);

(ii) that
contains an exclusivity clause that restricts the Company or any of its Subsidiaries or a covenant not to compete in any line of business
with any person in any geographical area that restricts the Company or any of its Subsidiaries or that otherwise restricts the Company
or any of its Subsidiaries from freely providing products or services to any customer or potential customer, or that restricts the right
of the Company or any of its Subsidiaries to sell to or purchase from any other person;

(iii) that
relates to the acquisition or disposition of any business (whether by merger, sale of stock or assets or otherwise) at any time since
the Lookback Date, other than those related to the Company’s efforts to seek the acquisition of an operating company prior to the
acquisition of Serve;

(iv) that is with any Related Party of the Company or any of its Subsidiaries;

(v) that
grants to the counterparty a right of first refusal, first offer or first negotiation outside of the ordinary course of business of the
Company, except for any such preemptive or similar rights in favor of the equity holders of Ionetix that will be terminated or extinguished
in connection with the Merger; or

(vi) that
grants the other party or any third party “most favored nation” status or any similar rights.

(mm) Employee Benefits.

(i) “ Benefit
Plan ” means any plan, program, arrangement or agreement that is a pension, profit-sharing, savings, retirement, employment,
consulting, severance pay, termination, executive compensation, incentive compensation, deferred compensation, bonus, stock purchase,
stock option, phantom stock or other equity-based compensation, change-in-control, retention, salary continuation, vacation, sick leave,
disability, death benefit, group insurance, hospitalization, medical, dental, life (including all individual life insurance policies as
to which the Company is the owner, the beneficiary, or both), Code Section 125 “cafeteria” or “flexible” benefit,
employee loan, educational assistance or fringe benefit plan, program, arrangement or agreement, whether written or oral, including, without
limitation, any (A) “employee benefit plan” within the meaning of Section 3(3) of the Employee Retirement Income Security
Act of 1974, as amended, and the rules and regulations promulgated thereunder (“ ERISA ”) or (B) other employee
benefit plans, agreements, programs, policies, arrangements or payroll practices, whether or not subject to ERISA (including any funding
mechanism therefor now in effect or required in the future as a result of the transaction contemplated by this Agreement or otherwise),
which the Company or any of its Subsidiaries sponsors or maintains for the benefit of its current or former officer, director, employee,
leased employee, consultant or agent (or their respective beneficiaries), or with respect to which the Company or any of its Subsidiaries
has, or could reasonably be expected to have, any direct or indirect present or future liability.

(ii) Each
Benefit Plan has been established, maintained and operated in all respects in accordance with its terms and in compliance with all
applicable provisions of applicable Laws, including Section 409A of the Code and the regulations and other guidance issued
thereunder, in each case, except as has not been and would not reasonably be expected to have, a Material Adverse Effect. There are
no investigations by any Governmental Authority, termination proceedings or other claims (except routine claims for benefits payable
under the Benefit Plans) or Actions pending in writing (or to the Company’s knowledge, orally) against any Benefit Plan or
asserting any rights to or claims for benefits under any Benefit Plan that would reasonably be expected to give rise to any material
liability. No non-exempt “prohibited transaction” (within the meaning of Section 406 of ERISA and Section 4975 of the
Code) has occurred or is reasonably expected to occur with respect to any Benefit Plan. No Benefit Plan is (A) subject to Section
412 of the Code, Title IV of ERISA or Section 302 of ERISA (including a “multiemployer” plan within the meaning of
Section 3(37) of ERISA), (B) a “multiple employer plan” as defined in Section 413(c) of the Code, or (C) a
“multiple employer welfare arrangement” within the meaning of Section 3(40) of ERISA. No Benefit Plan is subject to the
Laws of any jurisdiction other than the United States.

17

(iii) Neither
the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby shall, in connection with any
other event(s), (i) result in any payment or benefit becoming due to any current or former employee, contractor or director of the Company
or its Subsidiaries or under any Benefit Plan, (ii) increase any amount of compensation or benefits otherwise payable to any current or
former employee, contractor or director of the Company or its Subsidiaries or under any Benefit Plan, (iii) result in the acceleration
of the time of payment, funding or vesting of any benefits to any current or former employee, contractor or director of the Company or
its Subsidiaries or under any Benefit Plan, (iv) limit the right to merge, amend or terminate any Benefit Plan (except any limitations
imposed by applicable Law, if any), or (v) give rise to any “excess parachute payment” as defined in Section 280G(b)(l) of
the Code, any excise tax owing under Section 4999 of the Code or any other amount that would not be deductible under Section 280G of the
Code.

1. Representations, Warranties and Agreements of the Purchaser. The Purchaser represents and warrants to, and agrees with, the Company, as of the date hereof and as of the applicable Closing Date, the following:

(a) The
Purchaser has the knowledge and experience in financial and business matters necessary to evaluate the merits and risks of its prospective
investment in the Company, and has carefully reviewed and understands the risks of, and other considerations relating to, the purchase
of Shares and the tax consequences of the investment. The Purchaser has adequate means of providing for its current and anticipated financial
needs and contingencies and is able to bear the economic risks of the investment for an indefinite period of time and has no need for
liquidity of the investment in the Shares. The Purchaser can afford the loss of his, her or its entire investment.

(b) The
Purchaser is acquiring the Shares for investment for his, her or its own account and not with the view to, or for resale in
connection with, any distribution thereof. The Purchaser understands and acknowledges that the Offering and sale of the Shares have
not been registered under the Securities Act or any state securities Laws, by reason of a specific exemption from the registration
provisions of the Securities Act and applicable state securities Laws, which depends upon, among other things, the bona fide nature
of the investment intent as expressed herein. The Purchaser further represents that he, she or it does not have any contract,
undertaking, agreement or arrangement with any person to sell, transfer or grant participation to any third person with respect to
any of the Shares, other than with respect to an Affiliate of the Purchaser. The Purchaser understands and acknowledges that the
Offering of the Shares will not be registered under the Securities Act nor under the state securities laws on the ground that the
sale of the Shares to the Purchaser as provided for in this Agreement and the issuance of securities hereunder is exempt from the
registration requirements of the Securities Act and any applicable state securities laws. The Purchaser is an “accredited
investor” as defined in Rule 501 of Regulation D as promulgated by the SEC under the Securities Act for the reason(s)
specified on the Accredited Investor Certification attached hereto as completed by the Purchaser, and Purchaser shall submit to the
Company such further assurances of such status as may be reasonably requested by the Company. The Purchaser resides in the
jurisdiction set forth on the Purchaser’s Omnibus Signature Page affixed hereto. If the Purchaser is, with respect to the
Company, (i) a predecessor of the Company; (ii) an affiliated issuer; (iii) a director, executive officer, other officer
participating in the offering, general partner or managing member of the Company; (iv) any beneficial owner of twenty percent (20%)
or more of the Company’s outstanding voting equity securities, calculated on the basis of voting power; (v) any promoter
connected with the Company in any capacity at the time of such sale; (vi) any investment manager of the Company if the Company is a
pooled investment fund; (vii) any person that has been or will be paid (directly or indirectly) remuneration for solicitation of
purchasers in connection with the Offering; (viii) any general partner or managing member of any such investment manager or
solicitor; or (ix) any director, executive officer or other officer participating in the offering of any such investment manager or
solicitor or general partner or managing member of such investment manager or solicitor (each such category, a “ Covered
Person ”), the Purchaser has not taken any of the actions set forth in, and is not subject to, the disqualification
provisions of Rule 506(d)(1) of the Securities Act.

(c) The
Purchaser (i) if a natural person, represents that he or she is the greater of (A) 21 years of age or (B) the age of legal majority in
his or her jurisdiction of residence, and has full power and authority to execute and deliver this Agreement and all other related agreements
or certificates and to carry out the provisions hereof and thereof; (ii) if a corporation, partnership, limited liability company, association,
joint stock company, trust, unincorporated organization or other entity, represents that such entity is duly organized, validly existing
and in good standing under the Laws of the state or jurisdiction of its organization, the consummation of the transactions contemplated
hereby is authorized by, and will not result in a violation of applicable Law or its charter or other organizational documents, such entity
has full power and authority to execute and deliver this Agreement and all other related agreements or certificates and to carry out the
provisions hereof and thereof and to purchase and hold the Shares, the execution and delivery of this Agreement has been duly authorized
by all necessary action, this Agreement has been duly executed and delivered on behalf of such entity and is a legal, valid and binding
obligation of such entity; or (iii) if executing this Agreement in a representative or fiduciary capacity, represents that he, she or
it has full power and authority to execute and deliver this Agreement in such capacity and on behalf of the subscribing individual, ward,
partnership, trust, estate, corporation, or limited liability company or partnership, or other entity for whom the Purchaser is executing
this Agreement, and such individual, partnership, ward, trust, estate, corporation, or limited liability company or partnership, or other
entity has full right and power to perform pursuant to this Agreement and make an investment in the Company, and represents that this
Agreement constitutes a legal, valid and binding obligation of such entity. The execution and delivery of this Agreement will not violate
or be in conflict with any order, judgment, injunction, agreement or controlling document to which the Purchaser is a party or by which
it is bound, except for any violation or conflict that, individually or in the aggregate, has not had and would not reasonably be expected
to have a material adverse effect on the ability of the Purchaser to perform its obligations under this Agreement and the other Transaction
Documents or to consummate any transactions contemplated hereby or thereby.

18

(d) The
Purchaser understands that the Shares are being offered and sold to him, her or it in reliance on specific exemptions from the registration
requirements of United States federal and state securities Laws and that the Company is relying in part upon the truth and accuracy of,
and the Purchaser’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Purchaser
set forth herein in order to determine the availability of such exemptions and the eligibility of the Purchaser to acquire such securities.
The Purchaser further acknowledges and understands that the Company is relying on the representations and warranties made by the Purchaser
hereunder and that such representations and warranties are a material inducement to the Company to sell the Shares to the Purchaser. The
Purchaser further acknowledges that without such representations and warranties of the Purchaser made hereunder, the Company would not
enter into this Agreement with the Purchaser.

(e) The
Purchaser understands that, other than as expressly provided in the Registration Rights Agreement, the Company does not currently intend
to register the Shares under the Securities Act at any time in the future; and the undersigned will not immediately be entitled to the
benefits of Rule 144 with respect to the Shares. The Purchaser understands that no public market exists for the Company’s Common
Stock and that there can be no assurance that any public market for the Common Stock will exist or continue to exist. The Company’s
Common Stock is not approved for quotation on OTC Markets or any other quotation system or listed on any exchange.

(f) The
Purchaser has received, reviewed and understood the information about the Company, including all Disclosure Materials provided to it
by the Company and/or the Placement Agent (at the Company’s direction), and has had an opportunity to discuss the
Company’s business, management and financial affairs with the Company’s management. The Purchaser understands that such
discussions, as well as any Disclosure Materials provided by the Company and/or the Placement Agent (at the Company’s
direction), were intended to describe the aspects of the Company’s business and prospects and the Offering which the Company
believes to be material, but were not necessarily a thorough or exhaustive description and except as expressly set forth in this
Agreement (as modified by the disclosures on the Disclosure Schedule or the Delivered Super 8-K (excluding any disclosures contained
under the heading “Risk Factors,” any disclosures of risks included in any “forward looking statements” or
disclosures that are cautionary, predictive or forward-looking in nature)), the Company makes no representation or warranty with
respect to the completeness of such information and makes no representation or warranty of any kind with respect to any information
provided by any entity other than the Company. Some of such information may include projections as to the future performance of the
Company, which projections may not be realized, may be based on assumptions which may not be correct and may be subject to numerous
factors beyond the Company’s control. The Purchaser acknowledges that he, she or it is not relying upon any person or entity,
other than the Company and its officers and directors, in making its investment or decision to invest in the Company. In entering
into this Agreement, the Purchaser has not relied on any oral or, except as otherwise expressly set forth in the Transaction
Documents or the Disclosure Materials, written information provided by the Company or Ionetix or by the Company’s or
Ionetix’s affiliates, agents, employees, representatives or trustees or by any other agent or broker. No agent, employee or
representative of the Company or Ionetix or other agent or broker has been authorized to make, and the Purchaser has not relied on,
any statements other than those expressly set forth in the Transaction Documents or the Disclosure Materials. Without limiting or
derogating from Section 3(ee), the Purchaser understands and represents that he, she or it is purchasing the Shares notwithstanding
the fact that the Company may disclose in the future certain material information the Purchaser has not received that is not
required to be disclosed in the Super 8-K, including (without limitation) financial statements of the Company and/or Ionetix for the
current fiscal period, and any subsequent period financial statements that will be filed with the SEC, that he, she or it is not
relying on any such information in connection with his, her or its purchase of the Shares. Each Purchaser has sought such
accounting, legal and tax advice as the Purchaser has considered necessary to make an informed investment decision with respect to
his, her or its acquisition of the Shares.

(g) The
Purchaser acknowledges that neither the Company nor the Placement Agent is acting as a financial advisor or fiduciary of the Purchaser
(or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby, and no investment
advice has been given by the Company, the Placement Agent or any of their respective representatives or agents in connection with the
Transaction Documents and the transactions contemplated hereby and thereby. The Purchaser further represents to the Company that the Purchaser’s
decision to enter into the Transaction Documents has been based solely on the independent evaluation by the Purchaser and the Purchaser’s
representatives.

19

(h) As
of the applicable Closing, all actions on the part of the Purchaser, and its officers, directors and partners, if applicable, necessary
for the authorization, execution and delivery of this Agreement and the Registration Rights Agreement and the performance of all obligations
of the Purchaser hereunder and thereunder shall have been taken, and this Agreement and the Registration Rights Agreement, assuming due
execution by the parties hereto and thereto, constitute valid and legally binding obligations of the Purchaser, enforceable in accordance
with their respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar Laws relating to, or affecting generally, the enforcement of creditors’ rights
and remedies.

(i) The
Purchaser represents that neither it nor, to its knowledge, any person or entity controlling, controlled by or under common control
with it, nor any person having a beneficial interest in the Purchaser, nor any person on whose behalf the Purchaser is acting: (i)
is a person listed in the Annex to Executive Order No. 13224 (2001) issued by the President of the United States (Executive Order
Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support Terrorism); (ii) is named on
the List of Specially Designated Nationals and Blocked Persons maintained by the U.S. Office of Foreign Assets Control; (iii) is a
non-U.S. shell bank or is providing banking services indirectly to a non-U.S. shell bank; (iv) is a senior non-U.S. political figure
or an immediate family member or close associate of such figure; or (v) is otherwise prohibited from investing in the Company
pursuant to applicable U.S. anti-money laundering, anti-terrorist and asset control Laws, regulations, rules or orders (categories
(i) through (v), each a “ Prohibited Purchaser ”). The Purchaser (A) agrees to provide the Company, promptly
upon request, all information that the Company reasonably deems necessary or appropriate to comply with applicable U.S. anti-money
laundering, anti-terrorist and asset control Laws, regulations, rules and orders and (B) consents to the disclosure to U.S.
regulators and law enforcement authorities by the Company and its Affiliates and agents of such information about the Purchaser as
the Company reasonably deems necessary or appropriate to comply with applicable U.S. anti-money laundering, anti-terrorist and asset
control Laws, regulations, rules and orders. If the Purchaser is a financial institution that is subject to the USA Patriot Act, the
Purchaser represents that it has met all of its obligations under the USA Patriot Act. The Purchaser acknowledges that if, following
its investment in the Company, the Company reasonably believes that the Purchaser is a Prohibited Purchaser or is otherwise engaged
in suspicious activity or refuses to promptly provide information that the Company requests, the Company has the right or may be
obligated to prohibit additional investments, segregate the assets constituting the investment in accordance with applicable
regulations or immediately require the Purchaser to transfer the Shares. The Purchaser further acknowledges that neither the
Purchaser nor any of the Purchaser’s Affiliates or agents will have any claim against the Company or Ionetix for any form of
damages as a result of any of the foregoing actions.

(j) If the Purchaser
is an Affiliate of a non-U.S. banking institution (a “ Foreign Bank ”), or if the Purchaser receives deposits
from, makes payments on behalf of, or handles other financial transactions related to a Foreign Bank, the Purchaser represents and warrants
to the Company that: (1) the Foreign Bank has a fixed address, other than solely an electronic address, in a country in which the Foreign
Bank is authorized to conduct banking activities; (2) the Foreign Bank maintains operating records related to its banking activities;
(3) the Foreign Bank is subject to inspection by the banking authority that licensed the Foreign Bank to conduct banking activities;
and (4) the Foreign Bank does not provide banking services to any other Foreign Bank that does not have a physical presence in any country
and that is not a regulated Affiliate.

(k) The
Purchaser or its duly authorized representative realizes that because of the inherently speculative nature of businesses of the kind conducted
and contemplated by the Company, the Company’s financial results may be expected to fluctuate from month to month and from period
to period and will, generally, involve a high degree of financial and market risk that could result in substantial or, at times, even
total losses for investors in securities of the Company. The Purchaser has considered the risk factors in the Delivered Super 8-K before
deciding to invest in the Shares.

(l) The
Purchaser is not subscribing for Shares as a result of or subsequent to any advertisement, article, notice or other communication, published
in any newspaper, magazine or similar media or broadcast over television, radio, or the internet, or presented at any seminar or meeting,
or any solicitation of a subscription by a person not previously known to the Purchaser in connection with investments in securities generally.

(m) The
Purchaser acknowledges that no U.S. federal or state agency or any other government or governmental agency has passed upon the Shares
or made any finding or determination as to the fairness, suitability or wisdom of any investments therein.

20

(n) Other
than consummating the transactions contemplated hereunder, the Purchaser has not directly or indirectly, nor has any individual or entity
acting on behalf of or pursuant to any understanding with the Purchaser, executed any purchases or sales, including Short Sales (as defined
below), of the securities of the Company during the period commencing at the time the Purchaser was first contacted by the Company or
any other individual or entity representing the Company (including the Placement Agent) regarding the transactions contemplated hereunder.
Notwithstanding the foregoing, in the case of the Purchaser being a multi-managed investment vehicle whereby separate portfolio managers
manage separate portions of the Purchaser’s assets and the portfolio managers do not communicate or share information with, and
have no direct knowledge of the investment decisions made by, the portfolio managers managing other portions of the Purchaser’s
assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Shares covered by this Agreement. Other than to other individuals or entities party to this
Agreement, or to the Purchaser’s representatives, agents or advisors, such Purchaser has maintained the confidentiality of all disclosures
made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing,
for avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to the identification of the availability of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions
in the future. For purposes of this Agreement, “ Short Sales ” means all “short sales” as defined
in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include the location and/or reservation of borrowable
shares of Common Stock).

(o) The
Purchaser is aware that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of the Shares and other
activities with respect to the Shares by the Purchaser, and will comply with such anti-manipulation rules of Regulation M.

(p) All
of the information concerning the Purchaser set forth herein, and any other information furnished by the Purchaser in writing to the Company
or the Placement Agent for use in connection with the transactions contemplated by this Agreement, is true, correct and complete in all
material respects as of the date of this Agreement, and, if there should be any material change in such information prior to the Purchaser’s
purchase of the Shares, the Purchaser will promptly furnish revised or corrected information to the Company.

(q) The
Purchaser has reviewed with its own tax advisors the U.S. federal, state, local and foreign tax consequences of this investment and the
transactions contemplated by the Transaction Documents. With respect to such matters, the Purchaser relies solely on such advisors and
not on any statements or representations of the Company or any of its agents, written or oral. The Purchaser understands that it (and
not the Company) shall be responsible for its own tax liability that may arise as a result of this investment or the transactions contemplated
by the Transaction Documents.

(r) If
the Purchaser is not a United States person (as defined by Section 7701(a)(30) of the Internal Revenue Code of 1986, as amended), the
Purchaser hereby represents that it has satisfied itself as to the observance in all material respects of the Laws of its jurisdiction
in connection with any invitation to subscribe for the Shares or any use of this Agreement, including (a) the legal requirements within
its jurisdiction for the purchase of the Shares; (b) any foreign exchange restrictions applicable to such purchase; (c) any governmental
or other consents that may need to be obtained; and (d) the income tax and other tax consequences, if any, that may be relevant to the
purchase, holding, redemption, sale or transfer of the Shares. The Purchaser’s subscription and payment for and continued beneficial
ownership of the Shares will not violate any applicable securities or other Laws of the Purchaser’s jurisdiction.

(s) The
Purchaser represents that it is not a “foreign person” for purposes of Section 721 of the Defense Production Act of 1950 (as
amended) or the rules or regulations promulgated thereunder (including 31 C.F.R. Part 800 and 31 C.F.R. part 801); provided, however,
that if the Purchaser is a “foreign person” for such purposes, it agrees that it will not (i) obtain any control rights over
the Company, including the ability to determine, direct, or decide important matters affecting the Company; (ii) have access to any material
nonpublic technical information in the possession of the company; (iii) obtain membership or observer rights on the Board of Directors
or the right to nominate an individual to a position on the Board of Directors; or (iv) have any involvement, other than through voting
of shares, in substantive decision making of the Company regarding the use, development, acquisition or release of the Company’s
technology.

21

(t) (For
ERISA plans only) The fiduciary of the Employee Retirement Income Security Act of 1974 (“ ERISA ”) plan (the
“ Plan ”) represents that such fiduciary has been informed of and understands the Company’s investment objectives,
policies and strategies, and that the decision to invest “plan assets” (as such term is defined in ERISA) in the Company is
consistent with the provisions of ERISA that require diversification of plan assets and impose other fiduciary responsibilities. The Purchaser
fiduciary or Plan (a) is responsible for the decision to invest in the Company; (b) is independent of the Company or any of its Affiliates;
(c) is qualified to make such investment decision; and (d) in making such decision, the Purchaser fiduciary or Plan has not relied primarily
on any advice or recommendation of the Company or any of its Affiliates.

(u) If
the Purchaser is a Covered Person, neither the Purchaser nor, to the Purchaser’s knowledge, any of its directors, executive officers,
other officers that may serve as a director or officer of any company in which it invests, general partners or managing members is subject
to any Disqualification Events, except for Disqualification Events covered by Rule 506(d)(2)(ii) or (iii) under the Securities Act, and
disclosed reasonably in advance of the applicable Closing in writing in reasonable detail to the Company.

(v) The
Purchaser understands that there are substantial restrictions on the transferability of the Shares and that the certificates or book-entry
positions representing the Shares shall bear a restrictive legend in substantially the following form (and a stop-transfer order may be
placed against transfer of such certificates or other instruments):

THE SECURITIES REPRESENTED BY THIS
BOOK-ENTRY POSITION HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED
THEREUNDER (THE “ SECURITIES ACT ”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY
INTEREST THEREIN MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT
THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION
EXISTS AND THE COMPANY RECEIVES AN OPINION OF COUNSEL, WHICH COUNSEL AND OPINION ARE REASONABLY SATISFACTORY TO THE COMPANY, THAT
SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR APPLICABLE STATE SECURITIES LAWS OR (3) SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES
ACT.

In addition, if the Purchaser is an
Affiliate of the Company, certificates or book-entry positions evidencing the Shares issued to the Purchaser may bear a customary “Affiliates”
legend.

Any fees (with
respect to the Company’s transfer agent (the “ Transfer Agent ”), counsel or otherwise) associated with
the removal of such legend(s) shall be borne by the Company.

The Company shall be obligated to
promptly reissue unlegended certificates or book entry positions upon the request of any holder thereof at such time as the
securities evidenced by such certificates or book entry positions (x) are sold pursuant to Rule 144 or another applicable exemption
from the registration requirements of the Securities Act has been satisfied, provided that the Company and its Transfer Agent have
received a legal opinion in such form as the Company’s counsel reasonably requests, or (y) are sold pursuant to an effective
resale registration statement under the Securities Act, or (z) are covered by an effective resale registration statement under the
Securities Act and are Legend Removal Shares (as defined in the next sentence). If a resale registration statement under the
Securities Act covering the Shares becomes effective, then the Company shall cause legal counsel to the Company, at the
Company’s expense: (a) to issue to the Transfer Agent for the Common Stock, within one (1) Trading Day after the effective
date thereof, a “blanket” legal opinion in customary form to the effect that the Registrable Securities covered by the
Registration Statement Shares have been registered for resale under the Securities Act and, if such counsel has received a signed
certificate in the form attached as Exhibit A to the Registration Rights Agreement (a “ Legend Removal
Certificate ”) from the holder of the Shares, may then be reissued without any legend or restriction relating to their
status as “restricted securities” as defined in Rule 144 (“ Legend Removal Shares ”), or,
otherwise, may then be reissued without any legend or restriction relating to their status as “restricted securities” as
defined in Rule 144 upon resale pursuant to such registration statement; and (b) promptly to amend such opinion to cause the Shares
to be Legend Removal Shares after later receipt of a Legend Removal Certificate from the Holder. Under the foregoing circumstances,
the Company shall cause its Transfer Agent to issue unlegended shares, in the case of clause (x) above, within one (1) Trading Day
after the Transfer Agent’s receipt of such opinion or, in the case of clause (y) above, within three (3) Trading Days after
the Transfer Agent’s receipt of such legal opinion with respect to Legend Removal Shares or otherwise within three (3) Trading
Days after the Transfer Agent’s receipt of evidence in customary form that the Shares have been sold pursuant to an effective
resale registration statement under the Securities Act, in either case via DWAC or as otherwise requested by the holder.

22

(w) If
the Purchaser is an individual, then the Purchaser resides in the state or province identified in the address of the Purchaser set forth
on such Purchaser’s Omnibus Signature Page to this Agreement; if the Purchaser is a partnership, corporation, limited liability
company or other entity, then the office or offices of the Purchaser in which its principal place of business is identified in the address
or addresses of the Purchaser set forth on such Purchaser’s Omnibus Signature Page to this Agreement.

(x) The Purchaser understands that the Company prior to the Merger was a “shell company” as defined in Rule 12b-2 under
the Exchange Act, and that upon filing with the SEC of the Super 8-K reporting the consummation of the Merger and related transactions
and the transactions contemplated by this Agreement, and otherwise containing “Form 10 information” discussed below, the
Company will reflect therein that it is no longer a shell company. Pursuant to Rule 144(i), securities issued by a current or former
shell company (that is, the Shares) that otherwise meet the holding period and other requirements of Rule 144 nevertheless cannot be
sold in reliance on Rule 144 until one (1) year after the Company (a) is no longer a shell company; and (b) has filed current
“Form 10 information” (as defined in Rule 144(i)) with the SEC reflecting that it is no longer a shell company, and provided
that at the time of a proposed sale pursuant to Rule 144, the Company is subject to the reporting requirements of Section 13 or 15(d)
of the Exchange Act and has filed all reports and other materials required to be filed by Section 13 or 15(d) of the Exchange Act, as
applicable, during the preceding twelve (12) months (or for such shorter period that the issuer was required to file such reports and
materials), other than Form 8-K reports. As a result, the restrictive legends on certificates or book-entry positions for the Shares
cannot be removed except in connection with (i) an actual sale meeting the foregoing requirements or (ii) pursuant to an effective registration
statement.

(y) The
Purchaser, if and to the extent that it purchases Shares in any Subsequent Closing, represents that it (i)(A) has a substantive, pre-existing
relationship with the Company or (B) had direct contact by the Company or the Placement Agent outside of the Offering, and (ii) did not
contact the Company or the Placement Agent or become interested in the Offering as a result of reading or otherwise being aware of the
Super 8-K or any press release or any other public disclosure disclosing the terms of the Offering.

(z) To
effectuate the terms and provisions hereof, the Purchaser hereby appoints CSC Delaware Trust Company as its attorney-in-fact for the purpose
of carrying out the provisions of the Escrow Agreement, including, without limitation, taking any action on behalf of, or at the instruction
of, the Purchaser and executing any release notices required under the Escrow Agreement and taking any action and executing any instrument
that CSC Delaware Trust Company may deem necessary or advisable (and lawful) to accomplish the purposes hereof, in each case, subject
to and in accordance with the terms of this Agreement. All lawful acts done under the foregoing authorization are hereby ratified and
approved, and neither CSC Delaware Trust Company nor any designee nor agent thereof shall be liable for any acts of commission or omission,
for any error of judgment, for any mistake of fact or law except for acts of fraud, gross negligence or willful misconduct. This power
of attorney, being coupled with an interest, is irrevocable while the Escrow Agreement remains in effect.

1. Conditions to Company’s Obligations at Closing. The Company’s obligation to complete the sale and issuance of the Shares and deliver the Shares to the Purchaser and to consummate the other transactions contemplated hereby at the Initial Closing and, if applicable, a Subsequent Closing, shall be subject to the satisfaction or written waiver by the Company (in whole or in part) of the following conditions, to the extent such condition can be waived, in its sole discretion, on or prior to the Initial Closing Date and each Subsequent Closing Date, as applicable (provided, that any waiver by the Company of the condition set forth in Section 5 (f) shall require the prior written consent of the Purchaser):

(a) Receipt
of Payment. The Company shall have received payment, by certified or other bank check or by wire transfer of immediately available
funds, in the full amount of the Purchase Price for the number of Shares being purchased by the Purchaser at the Initial Closing and,
if applicable, a Subsequent Closing.

(b) Receipt
of Executed Transaction Documents. The Purchaser shall have executed and delivered to the Company the Omnibus Signature Page, Accredited
Investor Certification, the Purchaser Profile and the Anti-Money Laundering Information Form and the Selling Securityholder Questionnaire
(as defined in the Registration Rights Agreement).

23

(c) Representations
and Warranties. The representations and warranties made by the Purchaser in Section 4 hereof shall be true and correct in all respects
as of the date of this Agreement and as of such Closing Date with the same force and effect as if they had been made on and as of such
Closing Date (except to the extent any such representation or warranty expressly speaks as of an earlier date, in which case such representation
or warranty shall be true and correct in all respects as of such earlier date), except for the failure of any such representation or warranty
to be so true and correct as would not, individually or in the aggregate, have a material adverse effect on the ability of the Purchaser
to consummate the transactions contemplated hereby.

(d) Performance.
The Purchaser shall have performed or complied with in all material respects all obligations and covenants herein required to be performed
by the Purchaser on or prior to the applicable Closing.

(e) Effectiveness
of the Merger Transactions. The Merger and each of the other transactions contemplated by the Merger Agreement shall have been effected
and consummated.

(f) Minimum
Offering. In connection with the Initial Closing only, the Company shall have received proceeds from the Offering equal to or greater
than the Minimum Offering Amount (inclusive of the aggregate principal amount of SAFE Notes converted, any Insider Investment and any
Placement Agent Investment).

(g) Lock-Up
Agreements. All officers and directors of the Company after closing of the Merger and all holders of shares of Common Stock
issued in exchange for all of the equity securities of Ionetix in the Merger who held 5% or more of the total outstanding shares of
Ionetix after the closing of the Merger (each a “ Restricted Holder ”) shall have entered into lock-up
agreements with the Company and the Placement Agents, with customary terms and conditions reasonably satisfactory to the Company and
the Placement Agent, the earlier of: (i) twelve (12) months after the Closing Date or; six (6) months after the date on which the
Common Stock is first listed on any Nasdaq market tier, the New York Stock Exchange (“NYSE”) or NYSE American (the
“Restricted Period”) whereby they will agree to certain restrictions on the sale or disposition (including pledge) of
all of the Common Stock held by (or issuable to or acquired by) them (other than any Shares purchased by a Restricted Holder in the
Offering), with customary exceptions.

(h) Qualifications.
All Authorizations of, or notices to, any Governmental Authority that are required in connection with the transactions contemplated by
this Agreement, including the lawful issuance and sale of the Shares pursuant to this Agreement at each Closing except for Blue Sky law
permits and qualifications that may be properly obtained after such Closing and filing of a Notice of Exempt Offering of Securities on
Form D with the SEC under Regulation D which may be filed no later than fifteen (15) calendar days after the “date of first sale”
in the Offering.

1. Conditions to Purchaser’s Obligations at the applicable Closing. The Purchaser’s obligation to accept delivery of the Shares and to pay for the Shares to be issued to the Purchaser hereunder at the Initial Closing and, if applicable, a Subsequent Closing, and to consummate the other transactions contemplated hereby, shall be subject to the satisfaction by the Company or written waiver by the Purchaser (in whole or in part) of the following conditions, to the extent such condition can be waived, in its sole discretion, on or prior to the Initial Closing Date and each Subsequent Closing Date, as applicable:

(a) Representations
and Warranties. (i) The representations and warranties made by the Company (as modified by the disclosures on the Disclosure Schedule
or in the Delivered Super 8-K (excluding any disclosures (whether contained under the heading “Risk Factors,” in any “forward-looking
statements” disclaimer or in any other section) to the extent they are cautionary, predictive or forward-looking in nature) set
forth in Sections 3(a), 3(b), 3(c), 3(d), 3(e), 3(h), 3(i), and 3(dd) hereof (collectively, the “ Company Fundamental Representations ”)
shall be true and correct in all respects as of the date of this Agreement and as of such Closing Date with the same force and effect
as if they had been made on and as of such Closing Date (except to the extent any such representation or warranty expressly speaks as
of an earlier date, in which case such representation or warranty shall be true and correct in all respects as of such earlier date) and
(ii) the other representations and warranties made by the Company in Section 3 shall be true and correct in all material respects (without
giving effect to any limitation as to “materiality” or “Material Adverse Effect” or similar qualifier) as of the
date of this Agreement and as of such Closing Date with the same force and effect as if they had been made on and as of such Closing Date
(except to the extent any such representation or warranty expressly speaks as of an earlier date, in which case such representation or
warranty shall be true and correct in all material respects as of such earlier date).

24

(b) Performance.
The Company shall have performed or complied with in all material respects all obligations and covenants herein required to be performed
by it on or prior to the applicable Closing.

(c) Receipt
of Executed Transaction Documents. The Company shall have duly executed and delivered to the Placement Agent on behalf of the Purchaser
the Registration Rights Agreement and the Escrow Agreement.

(d) Effectiveness
of the Merger Transactions. The Merger and each of the other transactions contemplated by the Merger Agreement shall have been effected
and consummated.

(e) Minimum
Offering. In connection with the Initial Closing only, the Company shall have received proceeds from the Offering equal to or greater
than the Minimum Offering Amount (inclusive of any Insider Investment and any Placement Agent Investment).

(f) Equity
Incentive Plan. The Board of Directors and the stockholders of the Company shall have duly adopted the EIP as described in Recital
B above.

(g) Certificate.
At each applicable Closing, an executive officer of the Company shall have duly executed and delivered or caused to be delivered to the
Placement Agent a certificate addressed to the Purchaser and the Placement Agent certifying as to the satisfaction of the conditions set
forth in Section 6(a) and Section 6(b) as of the applicable Closing Date.

(h) Good
Standing. The Company and each of its Subsidiaries is a corporation or other business entity duly organized, validly existing, and
in good standing under the Laws of the jurisdiction of its formation.

(i) Judgments.
No judgment, writ, order, injunction, award or decree of or by any court, or judge, justice or magistrate, including any bankruptcy court
or judge, or any order of or by any Governmental Authority, shall have been issued, and no action or proceeding shall have been instituted
by any Governmental Authority, enjoining or preventing the consummation of the transactions contemplated hereby.

(j) Delivery
of Super 8-K and Merger Agreement. The Company shall have delivered to the Purchaser, at least two (2) Business Days prior to the
Closing, (A) (1) in the case of Purchasers participating in the Initial Closing, a substantially complete draft of the Current Report
on Form 8-K describing the Merger, the Offering and the related transactions, including “Form 10 information” (as defined
in Rule 144(i)(3) under the Securities Act) (the “ Draft Super 8-K ”), or (2) in the case of Purchasers participating
in any subsequent Closing, the Current Report on Form 8-K describing the Merger, the Offering and the related transactions, including
“Form 10 information” as filed by the Company with the SEC within four (4) Business Days after the closing of the Merger and
the Initial Closing of the Offering (which shall not materially deviate from the Draft Super 8-K) (the “ Super 8-K ”),
including any audited and interim unaudited financial statements of Ionetix and pro forma financial information reflecting the Merger,
as required by Item 9.01 of SEC Form 8-K (the Draft Super 8-K or Super 8-K, as the case may be, so delivered to the Purchaser, the “ Delivered
Super 8-K ”), (B) upon request of the Purchaser a copy of any exhibit to the Draft Super 8-K or the Super 8-K, as applicable
(in the form filed or intended to be filed with the SEC) , and (C) a substantially complete draft of the Merger Agreement and each other
material transaction document contemplated by or related to the Merger Agreement, including the disclosure schedules thereto. For the
avoidance of doubt, such delivery shall be deemed to have been effected to the extent such document has been filed with the SEC pursuant
to its Electronic Data Gathering and Retrieval System.

(k) Legal
Opinion. Lucosky Brookman, LLP, legal counsel for the Company, shall deliver an opinion addressed to the Purchaser and the Placement
Agent, dated as of the applicable Closing Date, in form and substance reasonably acceptable to the Placement Agent.

(l) Compliance
with Laws. The transactions contemplated by this Agreement and the other Transaction Documents, including the sale and issuance of
the Shares, shall be legally permitted by all Laws and regulations to which the Company is subject or which are otherwise applicable to
the transactions contemplated by the Transaction Documents.

25

(m) Qualifications.
All Authorizations of, or notices to, any Governmental Authority that are required in connection with the transactions contemplated by
this Agreement, including the lawful issuance and sale of the Shares pursuant to this Agreement at each Closing, shall have been delivered
or obtained and effective as of such Closing except for Blue Sky law permits and qualifications that may be properly obtained after such
Closing and filing of a Notice of Exempt Offering of Securities on Form D with the SEC under Regulation D which may be filed no later
than fifteen (15) calendar days after the “date of first sale” in the Offering.

| | (n) | No Material Adverse Effect. There shall have been no Material Adverse Effect. |

| | 7. | Indemnification. |

(a) In addition
to the indemnity provided to the Purchaser in the applicable Registration Rights Agreement, the Company agrees to indemnify and hold
harmless the Purchaser and its Affiliates, and its and their respective directors, officers, stockholders, equity holders, members,
managers, partners, employees, attorneys, consultants, representatives and agents (and any other persons with a functionally
equivalent role of a person holding such titles notwithstanding a lack of such title or any other title), each person who controls
the Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors,
officers, stockholders, equity holders, members, managers, partners, employees, attorneys, consultants, representatives and agents
(and any other persons with a functionally equivalent role of a person holding such titles notwithstanding a lack of such title or
any other title) of such controlling person (collectively, the “ Purchaser Indemnitees ”), from and against
all losses, liabilities, claims, damages, costs, fees, charges, Taxes, judgements, fines, penalties and expenses whatsoever
(including, but not limited to, amounts paid in settlement and any and all out-of-pocket expenses, including attorneys’ fees
and expenses, incurred in investigating, preparing or defending against any litigation commenced or threatened) (collectively,
“ Indemnified Liabilities ”) arising out of or relating to: (i) the inaccuracy, violation or breach of any
of the Company’s representations or warranties made in Section 3 of this Agreement; (ii) any breach or failure to perform by
the Company of any of its covenants and obligations contained herein or (iii) any Action brought or made against such Purchaser
Indemnitee by a third party (including for these purposes a derivative action brought on behalf of the Company) and arising out of,
relating to or resulting from (A) the execution, delivery, performance or enforcement of the Transaction Documents or the Merger
Agreement or the transactions contemplated hereby or thereby, including the issuance of the Shares and the Merger or (B) the status
of the Purchaser as an investor in the Company pursuant to the transactions contemplated hereby or by the other Transaction
Documents. To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make
the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities that is permissible under applicable
Law. The liability of the Company under this paragraph shall not exceed the total Purchase Price paid by the Purchaser hereunder,
except in the case of fraud.

(b) The
Company shall have the right to control the investigation and defense of any Action for which a Purchaser Indemnitee may be entitled to
indemnification hereunder with counsel reasonably satisfactory to such Purchaser Indemnitee, at the sole cost and expense of the Company,
upon written notice to the applicable Purchaser Indemnitee; provided, that (i) such notice contains confirmation that the Company
has agreed to indemnify the Purchaser Indemnitee (subject to the limitations on indemnification set forth herein) for the Indemnified
Liabilities arising out of, relating to or resulting from such Action and (ii) the Company shall not be entitled to assume or control
the investigation and defense, if (A) such claim seeks non-monetary, equitable or injunctive relief or alleges any violation of criminal
Law or (B) the Company is also a party and the Purchaser Indemnitee determines in good faith after consultation with counsel that there
may be one or more legal defenses available to such Purchaser Indemnitee that are different or additional to those available to the Company.
If the Company assumes the investigation and defense of such Action in accordance herewith, the Purchaser Indemnitee may retain separate
co-counsel at its sole cost and expense and participate in the investigation and defense of such Action.

(c) Notwithstanding
anything to the contrary herein, without the prior written consent of the Purchaser Indemnitee, the Company shall not, and shall not cause
or permit any of its Subsidiaries or its or their respective Related Parties to, negotiate, consent to or enter into any settlement, or
consent to the entry of any judgment, with respect to any Action for which such Purchaser Indemnitee may be entitled to indemnification
hereunder, unless such settlement (i) includes an unconditional release of such Purchaser Indemnitee from all liability arising out of
such proceeding, (ii) does not require any admission of wrongdoing by any Purchaser Indemnitee, and (iii) does not obligate or require
any Purchaser Indemnitee to take, or refrain from taking, any action.

26

(d) The
Purchaser acknowledges on behalf of itself and each Purchaser Indemnitee that, other than (i) for Actions seeking specific performance
of the obligations under this Agreement; or (ii) in the case of a breach or violation of this Agreement by the Company which has resulted
from either (A) intentional fraud or (B) a deliberate act or failure to act with actual knowledge that the act or failure to act constituted
or would result in a breach or violation, in each case, the sole and exclusive remedy of the Purchaser and the Purchaser Indemnitees with
respect to any and all claims relating to this Agreement shall be pursuant to the indemnification provisions (including the limitations
thereof) set forth in this Section 7.

1. Revocability; Binding Effect. The subscription hereunder may be revoked, in whole or in part, prior to the Initial Closing or any Subsequent Closing, as applicable, in the sole discretion of the Purchaser, for any reason or no reason, provided that written notice of revocation is sent and is received by the Company or the Placement Agent at least two (2) Business Days prior to the Initial Closing Date or the applicable Subsequent Closing Date. The Purchaser hereby acknowledges and agrees that this Agreement shall survive the death or disability of the Purchaser and shall be binding upon and inure to the benefit of the parties and their heirs, executors, administrators, successors, legal representatives and permitted assigns. If the Purchaser is more than one person, the obligations of the Purchaser hereunder shall be joint and several and the agreements, representations, warranties and acknowledgments herein shall be deemed to be made by and be binding upon each such person and such person’s heirs, executors, administrators, successors, legal representatives and permitted assigns.

| | 9. | Miscellaneous. |

(a) Modification . This
Agreement shall not be amended, modified or waived except by an instrument in writing signed by the Company and the holders of at
least a majority of the Shares and Other Shares; provided that this Agreement may not be amended and the observance of any term
hereof may not be waived with respect to any Purchaser without the written consent of such Purchaser if such amendment or waiver on
its face materially and adversely affects the rights of such Purchaser under this Agreement in a manner that is different than the
Other Purchasers. Any amendment, modification or waiver effected in accordance with this Section 9 (a) shall be binding upon the
Purchaser and each transferee of the Shares, each future holder of all such Shares, and the Company, its successors and assigns.

(b) Third-Party
Beneficiary . The Placement Agent shall be an express third-party beneficiary of the representations and warranties of the Company
and the Purchaser included in Sections 3 and 4 of this Agreement. This Agreement is intended for the benefit of the parties hereto and
their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other
person, except as otherwise set forth in Section 7 and this Section 9 (b).

(c) Notices . Any
notice, consents, waivers or other communication required or permitted to be given hereunder shall be in writing and will be deemed
to have been delivered: (i) upon receipt, when personally delivered; (ii) upon receipt when sent by certified mail, return receipt
requested, postage prepaid; (iii) upon receipt, when sent by facsimile (provided confirmation of transmission is mechanically or
electronically generated and kept on file by the sending party); (iv) when sent, if by e-mail (provided that such sent e-mail is
kept on file (whether electronically or otherwise) by the sending party and the sending party does not receive an automatically
generated message from the recipient’s e- mail server that such e-mail could not be delivered to such recipient); or (v) one
(1) Business Day after deposit with a nationally recognized overnight courier service with next day delivery specified, in each
case, properly addressed to the party to receive the same. The addresses, facsimile numbers and email addresses for such
communications shall be:

27

(i) if to the Company, at

JDEV Acquisition Corp.

with copies (which shall not constitute
notice) to:

Lucosky Brookman LLP

101 Wood Avenue South

Woodbridge, NJ
08830

Attn: Joseph Lucosky, Esq.

and

Foster Swift Collins & Smith PC

1700 East Beltline,
N.E.

Suite 200

Grand Rapids, MI 49525

Attn: Joel Farrar, Esq.

(ii) if to the Purchasers, at the address set forth on each such Omnibus Signature Page hereof

(or, in either case, to such other
address as the party shall have furnished in writing in accordance with the provisions of this Section).

(d) Assignability . This
Agreement and the rights, interests and obligations hereunder are not transferable or assignable by the Purchaser other than an
assignment of the rights, interests and obligations hereunder in connection with any transfer of the Shares by a Purchaser to a
Permitted Assignee (as such term is defined in the Registration Rights Agreement). For the avoidance of doubt, nothing in this
Section 9 (d) is intended to, or shall have the effect of, restricting or otherwise impairing any transfer of the Shares by the
Purchaser.

(e) Applicable Law . This Agreement and the other Transaction Documents and the transactions contemplated
hereby and thereby shall be governed by and construed in accordance with the Laws of the State of New York, without reference to the
principles thereof relating to the conflict of Laws. Any litigation based hereon, or arising out of, under or in connection with,
this Agreement or any other Transaction Document or the transactions contemplated hereby or thereby shall be brought and maintained
exclusively in the United States District Court for the Southern District of New York or the Supreme Court of the State of New York,
and the appellate courts therefrom, in each case sitting in New York County, New York. Each party irrevocably consents to the
service of process of any of the aforementioned courts in any such suit, action or proceeding by the mailing of copies thereof by
registered or certified mail, postage prepaid, return receipt requested, to such party’s address set forth in Section 9(c) ,
such service to become effective ten (10) days after such mailing.

(f) WAIVER
OF JURY TRIAL . EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION OR COUNTERCLAIM (WHETHER
BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT, THE TRANSACTIONS CONTEMPLATED
HEREBY OR THEREBY OR THE ACTIONS OF SUCH PARTY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT HEREOF.

(g) Form
D; Blue Sky Qualification. The Company agrees to timely file a Form D with respect to the Shares and to provide a copy thereof, promptly
upon request of the Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain
an exemption for, or to qualify the Shares for, sale to the Purchaser at such Closing under applicable securities or “Blue Sky”
laws of the states of the United States, and shall provide evidence of such actions promptly upon request of the Purchaser.

(h) Use
of Pronouns . All pronouns and any variations thereof used herein shall be deemed to refer to the masculine, feminine, neuter,
singular or plural as the identity of the person or persons referred to may require.

28

(i) Securities
Law Disclosure; Publicity. By 9:00 a.m., New York City time, on the trading day immediately following the Initial Closing, the Company
shall issue a press release (the “ Press Release ”) disclosing all material terms of the Offering. The Company
will also file the Super 8-K (and including as exhibits to such Super 8-K, the material Transaction Documents (including, without limitation,
this Agreement and the Registration Rights Agreement)) as soon as practicable following the closing date of the Merger but in no event
more than four (4) Business Days following the closing date of the Merger. Notwithstanding the foregoing, the Company shall not publicly
disclose the name of the Purchaser or an Affiliate of the Purchaser, or include the name of the Purchaser or an Affiliate of the Purchaser
in any press release or filing with the SEC (other than the Registration Statement) or any regulatory agency or principal trading market,
without the prior written consent of the Purchaser, except (i) as required by federal securities Law in connection with (A) any registration
statement contemplated by the Registration Rights Agreement and (B) the filing of final Transaction Documents with the SEC, or (ii) in
connection with a request by FINRA relating to the Form 211 to be filed by a market maker on the Company’s behalf, or (iii) to
the extent such disclosure is required by applicable Law, request of the staff of the SEC or of any regulatory agency or principal trading
market regulations, in which case the Company shall to the extent legally permissible provide the Purchaser with prior written notice
of such disclosure permitted under this sub-clause (ii). From and after the filing of the Super 8-K, no Purchaser shall be in possession
of any material, non-public information received from the Company or any of its respective officers, directors, employees or agents or
any other person acting on its behalf in connection with the Offering that is not disclosed in the Super 8-K unless the Purchaser shall
have executed a written agreement with the Company regarding the confidentiality and use of such information or is otherwise subject
to confidentiality restrictions. The Purchaser, severally and not jointly with the Other Purchasers, covenants that until such time as
the transactions contemplated by this Agreement are publicly disclosed by the Company as described in this Section 9 (i), the Purchaser
will maintain the confidentiality of all disclosures made to it in connection with such transactions (including the existence and terms
of such transactions), except to the extent such disclosure is required by applicable Law and then only after providing the Company with
advance notice of such disclosure to the extent legally permissible so that the Company may seek a protective order to prevent such disclosure.
In addition, the Purchaser acknowledges that it is aware that United States securities laws may restrict persons who have material, non-public
information about a company from purchasing or selling any securities of such company while in possession of such information. The provisions
of this Section 9 (i) are in addition to and not in replacement of any other confidentiality agreement, if any, between the Company and
the Purchaser.

(j) Non-Public
Information . Except for information (including the terms of this Agreement and the transactions contemplated hereby) that will
be disclosed in the Super 8-K and filed with the SEC, the Company shall not and shall cause each of its officers, directors, employees,
agents and other representatives, not to, provide the Purchaser with any material, non-public information regarding the Company without
the express prior written consent of the Purchaser.

(k) Entire
Agreement. This Agreement, together with the Registration Rights Agreement and each other Transaction Document, and all exhibits,
schedules and attachments hereto and thereto, including the Disclosure Schedule and any confidentiality agreement between the Purchaser
and the Company, constitute the entire agreement between the Purchaser and the Company with respect to the Offering and supersede all
prior oral or written agreements and understandings, if any, relating to the subject matter hereof.

(l) Share
Certificates. The Shares issued at any Closing will not be certificated but will be represented by book-entry positions on the books
of the Transfer Agent. If the Shares are subsequently certificated and any certificate or instrument evidencing any Shares is mutilated,
lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof,
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company and the Transfer Agent of such loss, theft or destruction and the execution by the holder thereof of a customary lost certificate
affidavit of that fact and an agreement to indemnify and hold harmless the Company and its Transfer Agent for any losses in connection
therewith and/or, if required by such Transfer Agent, a bond in such form and amount as is required by the Transfer Agent. The applicants
for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance
of such replacement Shares. If a replacement certificate or instrument evidencing any Shares is requested due to a mutilation thereof,
the Company may require delivery of such mutilated certificate or instrument as a condition precedent to any issuance of a replacement.

29

(m) Expenses.
Except as explicitly provided otherwise in this Agreement, all parties shall bear their own fees and expenses in connection with the Merger
and the Offering and certain due diligence activities relating thereto. Without limiting the foregoing, the Company shall pay all Transfer
Agent fees, stamp taxes and other Taxes and duties levied in connection with the sale and issuance of the Offering, and the Company shall
file all necessary Tax Returns and other documentation with respect to such fees, Taxes and duties, and the Company shall pay all fees
and expenses of its counsel in connection with the issuance of any opinion required by Section 6(k) above and of any opinion to the Transfer
Agent for the removal of any legend on the Shares. Any expenses of the Placement Agent (or any sub-agents), including fees and expenses
of their legal counsel, will be paid or reimbursed as agreed by Ionetix and the Company with the Placement Agent in the Placement Agent
Agreement by and between the Company and the Placement Agent. All other fees and expenses relating to the Merger and the Offering, including
but not limited to the Placement Agent’s cash commission, legal and accounting fees of Ionetix, any expenses of the Company will
be payable at each closing of the Offering from the proceeds thereof.

(n) Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together shall
constitute one and the same instrument. The exchange of copies of this Agreement and of signature pages that contain copies of an executed
signature page such as in .pdf format shall constitute effective execution and delivery of this Agreement as to the parties and may be
used in lieu of the original Agreement for all purposes. Signatures of the parties transmitted by facsimile or by e-mail of a document
in .pdf format shall be deemed to be their original signatures for all purposes.

(o) Severability.
Each provision of this Agreement shall be considered separable and, if for any reason any provision or provisions hereof are determined
to be invalid or contrary to applicable Law, such invalid or contrary provision shall be replaced with a valid provision that as closely
as possible reflects the parties’ intent with respect thereto, and invalidity or illegality shall not impair the operation of or
affect the remaining portions of this Agreement.

(p) Headings.
Paragraph titles are for descriptive purposes only and shall not control or alter the meaning of this Agreement as set forth in the text.

(q) Multiple
Closings. The Purchaser understands and acknowledges that there may be multiple Closings for the Offering.

(r) Additional
Information; Further Assurances. The Purchaser hereby agrees to furnish the Company such other information as the Company may reasonably
request prior to the applicable Closing with respect to its subscription hereunder. Each party hereto shall do and perform, or cause
to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments
and documents, as the other party hereto may reasonably request in order to effect the transactions contemplated hereby and to accomplish
the purposes of this Agreement and the consummation of the transactions contemplated hereby.

(s) Survival.
The parties, agree that, if the Closing occurs, (i) the Company Fundamental Representations shall survive the execution and delivery
of this Agreement for a period of three (3) years from the Initial Closing Date and (ii) the other representations and warranties of
the Company and the representations and warranties of the Purchaser contained in this Agreement shall survive the execution and
delivery of this Agreement for a period of one (1) year from the Initial Closing Date and in each case, shall in no way be affected
by any investigation or knowledge of the subject matter thereof made by or on behalf of the Purchaser or the Company. The covenants
and agreements contained in this Agreement (including the covenants and agreements set forth in Section 7 hereof) shall survive the
Closing and delivery of the Shares in accordance with their terms or, if no term is specified, such covenants and agreements shall
survive indefinitely. Notwithstanding anything herein to the contrary, in no event shall the Purchaser have any liability to the
Company or to any other person in connection with the Offering other than pursuant to this Agreement.

(t) Omnibus
Signature Page . This Agreement is intended to be read and construed in conjunction with the Registration Rights Agreement.
Accordingly, pursuant to the terms and conditions of this Agreement and the Registration Rights Agreement, it is hereby agreed that the
execution by the Purchaser of this Agreement, in the place set forth on the Omnibus Signature Page below, shall constitute agreement to
be bound by the terms and conditions hereof and the terms and conditions of the Registration Rights Agreement, with the same effect as
if each of such separate but related agreement were separately signed.

30

(u) Public
Disclosure . Neither the Purchaser nor any officer, manager, director, member, partner, stockholder, employee, Affiliate, Affiliated
person or entity of the Purchaser shall make or issue any press releases or otherwise make any public statements or make any disclosures
to any third person or entity with respect to the transactions contemplated herein and will not make or issue any press releases or otherwise
make any public statements of any nature whatsoever with respect to the Company without the Company’s express prior approval (which
may be withheld in the Company’s sole discretion), except to the extent such disclosure is required by Law, request of the staff
of the SEC or of any regulatory agency or principal trading market regulations.

(v) Potential
Conflicts . The Placement Agent, its sub-agents, legal counsel to the Company, the Placement Agent or Ionetix and/or their respective
Affiliates, principals, representatives or employees may now or hereafter own shares of the Company.

(w) Independent
Nature of the Purchaser’s Obligations and Rights. For avoidance of doubt, the obligations of the Purchaser under this Agreement,
the other Transaction Documents and any other agreements delivered in connection herewith are several and not joint with the obligations
of any Other Purchaser in connection with the Offering, and the Purchaser shall not be responsible in any way for the performance of the
obligations of any Other Purchaser in connection with the Offering. Nothing contained herein and no action taken by the Purchaser shall
be deemed to constitute the Purchaser as a partnership, an association, a joint venture, or any other kind of entity, or create a presumption
that the Purchaser is in any way acting in concert or as a group with any Other Purchaser in connection with the Offering with respect
to such obligations or the transactions contemplated by this Agreement or any other Transaction Document or any Other Subscription Agreement.
Except as specifically set forth herein, the Purchaser shall be entitled to independently protect and enforce its rights, including without
limitation the rights arising out of this Agreement, and it shall not be necessary for any other party to be joined as an additional party
in any proceeding for such purpose.

(x) Waiver
of Conflicts . Each party to this Agreement acknowledges that each of Lucosky Brookman LLP, counsel to the Company, Foster
Swift Collins & Smith PC, counsel to Ionetix, and Troutman Pepper Locke LLP, counsel to Network 1, may have in the past
performed and may continue to or in the future perform legal services for certain of the Purchasers in matters unrelated to the
transactions described in this Agreement, including financings and other matters. Accordingly, each party to this Agreement hereby
(a) acknowledges that it has had an opportunity to ask for information relevant to this disclosure; (b) acknowledges that Lucosky
Brookman LLP, Foster Swift Collins & Smith PC, and Troutman Pepper Locke LLP represented the Company, Ionetix and Network 1,
respectively, in the transaction contemplated by this Agreement and have not represented any individual Purchaser in connection with
such transaction; and (c) gives its informed consent to Lucosky Brookman LLP’s, Foster Swift Collins & Smith PC’s,
and Troutman Pepper Locke LLP’s representation of certain of the Purchasers in unrelated matters and to Lucosky Brookman
LLP’s, Foster Swift Collins & Smith PC’s, and Troutman Pepper Locke LLP’s representation of the Company,
Ionetix and Network 1, respectively, in connection with this Agreement and the transactions contemplated hereby.

(y) Adjustments.
In the event of any stock split, subdivision, dividend or distribution payable in shares of Common Stock (or other securities or rights
convertible into, or entitling the holder thereof to receive directly or indirectly shares of Common Stock), combination or other similar
recapitalization or event occurring after the date hereof, each reference in any Transaction Document to a number of Shares or the Per
Share Purchase Price shall be deemed to be amended to appropriately account for such event.

(z) Remedies.
The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed
by them in accordance with the terms hereof and that each party hereto may be entitled to seek protective orders, injunctive relief and
other remedies available at Law or in equity (including, without limitation, seeking specific performance or rescission of purchases,
sales and other transfers). The parties hereto agree not to raise any objections to the availability of the equitable remedy of specific
performance to prevent or restrain breaches of this Agreement by the Purchaser or the Company, as applicable, and to specifically enforce
the terms and provisions of this Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the respective
covenants and obligations of the Purchaser and the Company, as applicable, under this Agreement all in accordance with the terms of this
Section 9(z). Neither the Purchaser nor the Company, as applicable, shall be required to provide any bond or other security in connection
with seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of
this Agreement, all in accordance with the terms of this Section 9 (z).

31

(aa) Recourse.
Notwithstanding anything that may be expressed or implied in this Agreement or in any other Transaction Document, and notwithstanding
the fact that the Purchaser may be partnerships or limited liability companies, the Company hereto covenants, agrees and acknowledges
that no recourse under this Agreement or any Transaction Document shall be had against any the Purchaser’s future, present or former
Affiliates, or the Purchaser’s or its Affiliates’ respective future, present or former officers, directors, managers, employees,
partners, equity holders, controlling persons, members, agents, attorneys, representatives, successors or permitted assigns (the “ Purchaser
Parties ”) (other than the Purchaser and its successors and Permitted Assignees under this Agreement), whether by the enforcement
of any assessment or by any legal or equitable proceeding, or by virtue of any applicable Law, it being expressly agreed and acknowledged
that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any of the Purchaser Parties, as such,
for any obligation or liability of any party under this Agreement or any other Transaction Document for any claim based on, in respect
of or by reason of such obligations or liabilities or their creation; provided, however, nothing in this Section 9(aa) shall
relieve or otherwise limit the liability of the Purchaser or any of its successors or Permitted Assignees, for any breach or violation
of its obligations under such agreements, documents or instruments. The liability limitation provision in this Section 9(aa) shall survive
termination of this Agreement.

(bb) Use
of Proceeds. The Company shall use the net proceeds from the Offering for operating costs, capital expenditures, working capital and
other general corporate purposes. The foregoing includes [●]. [Beyond the current operations in Lansing, MI, one or more additional
markets will be identified]. The Offering proceeds will allow Ionetix to establish and grow its headcount and operational infrastructure
to support that expansion.

[Signature page follows.]

32

**

IN WITNESS WHEREOF, the Company has
duly executed this Agreement as of the [ ] day of [ ], 202[ ].

| JDEV Acquisition Corp. (to be renamed “Ionetix Corp.”) |

| By: |
| Name: |
| Title: |

33

HOW TO SUBSCRIBE
FOR SHARES IN THE PRIVATE OFFERING OF JDEV

Acquisition Corp. (TO BE RENAMED “IONETIX CORP.”)

1. Date and Fill in the number of Shares being purchased and complete and sign the Omnibus Signature Page.

---

1. Unless otherwise instructed by your broker representative or advisor:

---

Initial the Accredited Investor Certification in the appropriate place or places.

Complete and sign the Anti-Money Laundering Information
Form.

1. Complete and sign the Selling Securityholder Questionnaire

2. Docusign all forms. If your broker representative is with Network 1:

Network 1 Financial Securities, Inc.                                   .

Lori Tullman

Intuitive Venture Partners

122 E. 42nd St. 4th Floor

New
York, NY 10022

Email: [   ]

Phone: [   ]

5. If you are paying the Purchase Price by check, a certified or other bank check for the exact dollar amount of the Purchase
Price for the number of Shares you are purchasing should be made payable to the order of [        ].

Checks
take up to five (5) business days to clear. A check must be received by the Escrow Agent at least six (6) business days before the
closing date.

CSC Delaware Trust Contact: Matthew Bellucci
251 Little
Falls Drive

Wilmington, DE 19808-1674
USA

6. If you are paying the Purchase Price by wire transfer, you should send a wire transfer for the exact dollar amount of the
Purchase Price for the number of Shares you are purchasing according to the following instructions :

Bank:
[       ]

ABA Routing #: [       ]

SWIFT CODE: [       ]

Account Name: [       ]

Account #:
[       ]

Reference:
[       ]

CSC Delaware Trust Contact: Matthew Bellucci

251 Little
Falls Drive

Wilmington, DE 19808-1674

USA

Thank you for your interest.

34

JDEV Acquisition Corp. (to be
renamed “Ionetix Corp.”)

OMNIBUS SIGNATURE PAGE TO

SUBSCRIPTION AGREEMENT AND REGISTRATION
RIGHTS AGREEMENT

The undersigned, desiring to: (i)
enter into the Subscription Agreement, dated as of 1, 202 ,
between the undersigned, PubCo (to be renamed “Ionetix Corp.” a Delaware corporation (the “ Company ”),
and the other parties thereto, in the form furnished to the undersigned, (ii) enter into the Registration Rights Agreement (the “ Registration
Rights Agreement ”), among the undersigned, the Company and the other parties thereto, in the form furnished to the undersigned,
and (iii) purchase the Shares of the Company’s securities as set forth in the Subscription Agreement and below, hereby agrees to
purchase such Shares from the Company and further agrees to join the Subscription Agreement and the Registration Rights Agreement as a
party thereto, with all the rights and privileges appertaining thereto, and to be bound in all respects by the terms and conditions thereof.
The undersigned specifically acknowledges having read the representations section in the Subscription Agreement entitled “Representations
and Warranties of the Purchaser” and hereby represents that the statements contained therein are complete and accurate with respect
to the undersigned as a Purchaser.

IN WITNESS WHEREOF, the Purchaser hereby executes the Subscription
Agreement and the Registration Rights Agreement.

Dated: ____ ,
202[      ]

| x | $3.00 | = | $ |
| Number of Shares | Purchase Price per Share | | Total Purchase Price |

| PURCHASER (individual) | | PURCHASER (entity) |

| Signature | | Name of Entity |

| By: | |
| Print Name | Signature |

| Print Name: |
| Signature (if Joint Tenants
or Tenants in Common) | | Title: |

| Address of Principal Residence: | | Address of Executive Offices: |

| Social Security Number(s): | | IRS Tax Identification Number: |

| Telephone Number: | | Telephone Number: |

| Facsimile Number: | | Facsimile Number: |

| E-mail Address: | | E-mail Address: |

1 Will reflect the Closing Date. Not to be completed by Subscriber.

35

PUBCO

---

ACCREDITED
INVESTOR CERTIFICATION

(all
Purchasers must INITIAL where appropriate)

---

By
initialing you certify that:

PART
I: For Individual Purchasers Only

| Initial | | I
have a net worth, or joint net worth with my spouse or spousal equivalent, of more than US$1,000,000.
For purposes of calculating “net worth”: (i) my primary residence shall not be included
as an asset; (ii) indebtedness that is secured by my primary residence, up to the estimated fair
market value of the primary residence at the time of subscription, shall not be included as a liability
(except that if the amount of such indebtedness outstanding at the time of subscription exceeds
the amount outstanding sixty (60) days before such time, other than as a result of the acquisition
of the primary residence, the amount of such excess shall be included as a liability); and (iii)
indebtedness that is secured by my primary residence in excess of the estimated fair market value
of the primary residence at the time of subscription shall be included as a liability . “Spousal
equivalent” means a cohabitant occupying a relationship generally equivalent to that of a
spouse. “Joint net worth” is the aggregate net worth of a person and spouse or spousal
equivalent; assets do not need to be held jointly to be included in the calculation. |

| Initial | | I
have had an individual income in excess of US$200,000 in each of the two most recent calendar years,
or joint income with my spouse or spousal equivalent in excess of US$300,000 in each of those years,
and have a reasonable expectation of reaching the same income level in the current calendar year. (“Income” means annual adjusted gross income, as reported for federal income tax
purposes, plus (i) the amount of any tax-exempt interest income received; (ii) the amount of losses
claimed as a limited partner in a limited partnership; (iii) any deduction claimed for depletion;
(iv) amounts contributed to an IRA or Keogh retirement plan; (v) alimony paid; and (vi) any gains
excluded from the calculation of adjusted gross income pursuant to the provisions of Section 1202
of the Internal Revenue Code of 1986, as amended.) |

| Initial | | I hold in good standing
one of the following professional licenses: the General Securities Representative license (Series 7), the Private Securities Offerings
Representative license (Series 82), or the Investment Adviser Representative license (Series 65). |

| Initial | | I am a director or executive
officer of Ionetix Corp. or [PubCo]. |

36

PART
II: For Non-Individual Purchasers (Entities)

The
Purchaser is:

---

| Initial | | A bank, as defined in Section
3(a)(2) of the Securities Act or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Securities
Act, whether acting in an individual or a fiduciary capacity. |

| Initial | | A broker or dealer registered
under Section 15 of the Securities Exchange Act of 1934, as amended. |

| Initial | | An investment adviser registered
pursuant to Section 203 of the Investment Advisers Act of 1940 or registered pursuant to the laws of a state. |
| Initial | | An investment adviser relying
on the exemption from registering with the SEC under Section 203(l) or (m) of the Investment Advisers Act of 1940. |

| Initial | | An insurance company, as
defined in Section 2(a)(13) of the Securities Act. |

| Initial | | An investment company registered
under the Investment Company Act of 1940 or a business development company, as defined in Section 2(a)(48) of that act. |
| Initial | | A Small Business Investment
Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958. |
| Initial | | A Rural Business Investment
Company as defined in Section 384A of the Consolidated Farm and Rural Act. |
| Initial | | A plan established and
maintained by a state, its political subdivisions or any agency or instrumentality of a state or its political subdivisions for the
benefit of its employees, if the plan has total assets in excess of US$5 million. |
| Initial | | An employee benefit plan
within the meaning of Title I of the Employee Retirement Income Security Act of 1974, if the investment decision is being made by
a plan fiduciary, as defined in Section 3(21) of such act, and the plan fiduciary is either a bank, a savings and loan association,
an insurance company, or a registered investment adviser, or if the employee benefit plan has total assets in excess of US$5 million,
or if the employee benefit plan is a self-directed plan in which investment decisions are made solely by persons that are accredited
investors. |

| Initial | | A private business development
company, as defined in Section 202(a)(22) of the Investment Advisers Act of 1940. |

| Initial | | A corporation, Massachusetts
or similar business trust, partnership, or limited liability company or an organization described in Section 501(c)(3) of the Internal
Revenue Code of 1986, as amended, that was not formed for the specific purpose of acquiring the Securities, and that has total assets
in excess of US$5 million. |

| Initial | | A trust with total assets
in excess of US$5 million not formed for the specific purpose of acquiring the Securities, whose purchase is directed by a sophisticated
person as described in Rule 506(b)(2)(ii) under the Securities Act. |

| Initial | | An entity of a type not
listed above, that is not formed for the specific purpose of acquiring the Securities and owns investments in excess of US$5 million.
For purposes of this clause, “investments” means investments as defined in Rule 2a51-1(b) under the Investment Company
Act of 1940. |

| Initial | | A family office, as defined
in Rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940, that (i) has assets under management in excess of US$5 million;
(ii) is not formed for the specific purpose of acquiring the Securities and (iii) has a person directing the prospective investment
who has such knowledge and experience in financial and business matters so that the family office is capable of evaluating the merits
and risks of the prospective investment. |

| Initial | | A family client, as defined
in Rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940, of a family office meeting the requirements of the immediately
preceding clause and whose prospective investment in the Issuer is directed by that family office pursuant to subclause (iii) of
the immediately preceding item. |
| Initial | | An entity in which all
of the equity owners (whether entities themselves or natural persons) are accredited investors in one or more of the categories described
above. Please also see “Additional Questions for Certain Accredited Investors” below. |

Additional
Questions for Certain Accredited Investors:

If the undersigned entity has checked the last item above,
please complete the following:

(1)
What type of entity is the Purchaser?

(2)
List all equity owners of the Purchaser (whether entities themselves or natural persons):

(3) Have each
equity owner that is a natural person respond individually to Part I of this Certification. Have each equity owner that is an entity respond
separately to Part II of this Certification. Please attach these responses as additional pages to the back of this Certification.

Accredited Investor Certification Page 2

37

ANTI MONEY LAUNDERING
REQUIREMENTS

The USA PATRIOT Act

The USA PATRIOT Act is designed to
detect, deter, and punish terrorists in the United States and abroad. The Act imposes new anti-money laundering requirements on brokerage
firms and financial institutions. Since April 24, 2002 all brokerage firms have been required to have new, comprehensive anti-money laundering
programs.

To help you understand these efforts,
we want to provide you with some information about money laundering and our steps to implement the USA PATRIOT Act.

What is money laundering?

Money laundering is the process of
disguising illegally obtained money so that the funds appear to come from legitimate sources or activities. Money laundering occurs in
connection with a wide variety of crimes, including illegal arms sales, drug trafficking, robbery, fraud, racketeering, and terrorism.

How big is the problem and why
is it important?

The use of the U.S. financial system
by criminals to facilitate terrorism or other crimes could well taint our financial markets. According to the U.S. State Department, one
recent estimate puts the amount of worldwide money laundering activity at $1 trillion a year.

What are we required to do to
eliminate money laundering?

Under rules required by the USA PATRIOT
Act, our anti-money laundering program must designate a special compliance officer, set up employee training, conduct independent audits,
and establish policies and procedures to detect and report suspicious transaction and ensure compliance with such laws. As part of our
required program, we may ask you to provide various identification documents or other information. Until you provide the information or
documents we need, we may not be able to effect any transactions for you.

38

ANTI-MONEY LAUNDERING INFORMATION
FORM

The following is required in accordance
with the AML provision of the USA PATRIOT ACT.

(Please fill out and return with
requested documentation.)

**

| PURCHASER NAME: |
| ** |
| LEGAL ADDRESS: |

| SSN or TAX ID# |

| OF PURCHASER: |

| YEARLY INCOME: |
| **** |
| NET WORTH: | | * |
**

| ***** | For purposes of calculating “net worth”: (i)
your primary residence shall not be included as an asset; (ii) indebtedness that is secured by your primary residence, up to the estimated
fair market value of the primary residence at the time of subscription, shall not be included as a liability (except that if the amount
of such indebtedness outstanding at the time of subscription exceeds the amount outstanding sixty (60) days before such time, other than
as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability); and (iii) indebtedness
that is secured by your primary residence in excess of the estimated fair market value of the primary residence at the time of subscription
shall be included as a liability *.* |
**

39

| INVESTMENT OBJECTIVE(S) FOR ALL PURCHASERS: | |

| ADDRESS OF BUSINESS OR OF EMPLOYER: | |

---

---

| FOR PURCHASERS WHO ARE INDIVIDUALS: AGE: | |
| **** | |
| FOR PURCHASERS WHO ARE INDIVIDUALS: OCCUPATION: | |

_________________________________

---

| FOR PURCHASERS WHO ARE ENTITIES: Business Sector/Industry): | |
| **** | |
| BANK SECRECY ACT (BSA) REQUIREMENT | |

Identify and complete for
each of the 25% or more beneficial owner(s) of the entity as defined below: 1

| Name: __________________________ | Percent of Ownership: _______________ |

| Home Address (No P.O. Box): ________________________________ |

| Phone Number: __________________________ | Email Address: _____________________ | |

| Title (if applicable): ____________________________________ |

| Social Security Number: _____________________________________ | | Date of Birth: ______________ |

Please provide documents to verify
the identity of the beneficial owner(s), including a current valid issued government ID for each beneficial owner identified above.

---

| 1 | Beneficial
Owner: each individual, if any, who directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise
owns 25% or more of the equity interests of a legal entity investor: (A) a single individual with significant responsibility to control,
manage or direct a legal entity investor, including, (i) an executive officer or senior manager (e.g. Chief Executive Officer, Chief
Financial Officer, Chief Operating Officer, Managing Member, General Partner, President, Vice President or Treasurer) or (ii) any other
individual who regularly performs similar functions or (B) if a trust owns directly or indirectly, through any contract, arrangement,
understanding, relationship or otherwise, 25% or more of the equity interests of a legal entity investor, the beneficial owner shall
mean the trustee. It is the ultimate beneficial owner(s) that must be identified and not nominees. |

---

40

---

IDENTIFICATION & DOCUMENTATION AND SOURCE OF
FUNDS:

| | 1. | Please submit a copy of non-expired identification for the authorized
signatory(ies) on the investment documents, showing name, date of birth, address and signature. The address shown on the identification
document MUST match the Purchaser’s address shown on the Purchaser Signature Page. |

---

| Current
Driver’s License | or
Valid Passport | or
Identity Card |
(Circle one or more)

**

| 2. | If the Purchaser is a corporation, limited liability company,
trust or other type of entity, please submit the following requisite documents: (i) Articles of Incorporation, By-Laws, Certificate of
Formation, Operating Agreement, Trust or other similar documents for the type of entity; and (ii) Corporate Resolution or power of attorney
or other similar document granting authority to signatory(ies) and designating that they are permitted to make the proposed investment. |

| 3. | Please advise where the funds
were derived from to make the proposed investment: |

| Investments | Savings | Proceeds
of Sale | Other
__________ |
(Circle one or more)

**

Signature: __________________________________________

Print Name: __________________________________________

Title (if applicable): _________________________________________

Date: _____________________________________________________________

41

DISCLOSURE SCHEDULES

The following
disclosure schedules (the “ Disclosure Schedules ”) refer to the Subscription Agreement (the “ Subscription Agreement ”)
by and between the purchaser set forth on the Omnibus Signature Page thereof (the “ Purchaser ”) and [PubCo] (to
be renamed “Ionetix Corp.” upon consummation of the Merger (as defined therein)), a Delaware corporation (the “ Company ”)),
in connection with the private placement offering by the Company.

Nothing in the
following Disclosure Schedules is intended to broaden the scope of any representation or warranty contained in the Subscription Agreement
or to create any covenant on the part of the Company. To the extent more than one representation and warranty contained in the Subscription
Agreement requires the same disclosure, the appearance of such disclosure on any single item herein shall serve as disclosure for all
other representations and warranties to which such disclosure applies to the extent the relevance of such disclosure to such other representation
or warranty is readily apparent on its face.

Inclusion of
any item in the Disclosure Schedules (1) does not represent a determination that such item is material nor shall it be deemed to establish
a standard of materiality (it being acknowledged that the Company may disclose more than they may be required by the terms of the Subscription
Agreement), (2) does not represent a determination by the Company that such item did not arise in the ordinary course of business, and
(3) shall not constitute, or be deemed to be, an admission by the Company that such item or other matter is material, meets any standard
of materiality or meets all criteria set forth in the Subscription Agreement for inclusion. The items in the Disclosure Schedules are
descriptions of instruments or brief summaries of certain aspects of the Company and the business of the Company and are necessarily not
complete. Accordingly, the Disclosure Schedules are qualified in their entirety by reference to the specific provisions of the Subscription
Agreement, and are not intended to constitute, and shall not be construed as constituting, representations or warranties of the Company,
except as and to the extent provided in the Subscription Agreement, and subject to the limitations therein.

Capitalized terms
used but not defined herein shall have the same meanings ascribed to them in the Subscription Agreement. The headings in the following
schedules are for reference only and shall not affect the disclosures contained therein.

42

Schedule 3c

---

Capitalization

---

---

---

---

---

---

---

---

---

---

---

---

---

---

43

---

Schedule 3c(ii)

44

Schedule 3c(iii)

45

---

Schedule 3c(iv)

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

46

Schedule 3c(vi)

47

---

Schedule 3c(viii)

48

---

Schedule 3e

---

Conflicts

---

---

---

---

---

---

---

---

---

---

---

49

---

Schedule 3f

---

Litigation

---

---

---

---

---

---

---

---

---

---

50

Schedule 3k

---

Intellectual Property

---

---

---

---

---

---

---

---

---

---

---

51

---

Schedule 3m

---

Authorizations; Regulatory Compliance

---

---

---

---

---

---

---

---

---

---

---

---

---

52

---

Schedule 3n

---

Title to Real Property; Leaseholds

---

---

---

---

---

---

---

---

---

---

---

---

53

---

Schedule 3p

---

Certain Transactions

---

---

54

Schedule 3q

---

Rights of First Refusal

---

---

---

---

---

---

---

---

---

---

---

---

---

55

---

Schedule 3u

---

Material Changes

---

56

---

Schedule 3dd

---

Brokers

---

57

---

EXHIBIT A

Form of Registration Rights Agreement

58